CVS Health (CVS)

Company ID: 163 | CIK: 0000064803
10-Q view:
No 10-K data
No 10-Q YTD data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-K data
No 10-K data
No 10-Q YTD data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-Q YTD data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
No 10-Q 3M data
Segments are charted by their disclosed metrics (revenue, segment profit, etc.). Each line is a single segment. Reconciliation/corporate items are excluded. Major customers are shown as a percentage of revenue. Operational KPIs are grouped by metric concept; sub-metrics appear as separate lines.

Geographic Segments

No geographic segment data found.

Business Unit / Product Segments

Major Customers (% of Revenue)

No 10-Q data

Operational KPIs

Pharmacy Services locations (branches)

No 10-K data

Capacity (capacity)

No 10-Q data

Pharmacy claims processed (claims_count)

No 10-K data

Common stockholders (customers)

Physicians using CIMS (customers_served)

Headcount (headcount)

Medical Benefit Ratio (loss_ratio)

Accredited disease management programs (other)

No 10-K data

COVID-19 testing locations (other)

No 10-Q data

COVID-19 testing sites (other)

No 10-Q data

COVID-19 tests administered (other)

No 10-Q data

COVID-19 vaccines administered (other)

No 10-Q data

Capital expenditures (other)

No 10-Q data

Commercial paper outstanding (other)

No 10-K data

Commercial paper rate (other)

No 10-K data

Disease management programs (other)

No 10-K data

Distribution centers (other)

No 10-Q data

Effective income tax rate (other)

No 10-K data

Freestanding store mix (other)

No 10-K data

Freestanding store percentage (other)

No 10-K data

Freestanding store share (other)

No 10-K data

Freestanding stores (other)

Freestanding stores percentage (other)

No 10-K data

Freestanding stores share (other)

No 10-K data

Front store revenue mix (other)

Front store sales (other)

No 10-Q data

Front store sales share (other)

No 10-Q data

Front store share of total sales (other)

No 10-Q data

Generic Dispensing Rate (other)

No 10-Q data

Generic dispensing rate (other)

Generic dispensing rate (PBM) (other)

No 10-Q data

Generic dispensing rate (Retail) (other)

No 10-Q data

Generic dispensing rate (Retail/LTC) (other)

No 10-Q data

Gross margin rate (other)

No 10-K data

HealthHUB locations (other)

No 10-Q data

In-home health evaluations (other)

No 10-Q data

Independent prescription files purchased (other)

No 10-Q data

Infusion and enteral service branches (other)

No 10-Q data

Inventory loss rate (other)

No 10-K data

Inventory losses (other)

No 10-K data

Inventory shrinkage (other)

No 10-K data

Inventory shrinkage as percent of net sales (other)

No 10-K data

Inventory shrinkage rate (other)

No 10-K data

Inventory turns (other)

No 10-Q data

LTC hub pharmacies (other)

LTC pharmacies (other)

No 10-K data

LTC spoke pharmacies (other)

MA members in 4+ star plans (other)

No 10-K data

MA members in 4-star plans (other)

No 10-K data

Mail choice penetration (other)

No 10-Q data

Mail choice penetration rate (other)

Mail choice revenue (other)

No 10-K data

Mail order penetration rate (other)

Mail service pharmacies (other)

Markets with number one share (other)

No 10-Q data

Medical Benefit Ratio (other)

No 10-Q data

Medical clinics (other)

Medicare Advantage 4-star membership (other)

No 10-Q data

Medicare Advantage 4-star plan membership (other)

Medicare Advantage members in 4+ star plans (other)

No 10-Q data

Medicare Advantage star rating (other)

Medicare Advantage star rating coverage (other)

No 10-Q data

Medicare Part D premium revenue (other)

No 10-K data

Medicare Star Rating (other)

No 10-Q data

Members in 4+ star plans (other)

No 10-Q data

MinuteClinic clinics (other)

No 10-K data

MinuteClinic health care clinics (other)

No 10-K data

MinuteClinic healthcare clinics (other)

No 10-K data

MinuteClinic locations (other)

MinuteClinic third-party paid visits (other)

No 10-Q data

MinuteClinics (other)

No 10-Q data

Net revenue growth (other)

No 10-K data

Net revenue increase (other)

No 10-K data

Net sales growth (other)

No 10-K data

Net sales increase (other)

No 10-K data

Network participating pharmacies (other)

No 10-K data

Network pharmacies (other)

No 10-Q data

New retail drugstores opened (other)

No 10-K data

New stores opened (other)

Number of Reportable Segments (other)

OTC test kits sold (other)

No 10-Q data

Onsite pharmacies (other)

No 10-K data

Operating expense rate (other)

No 10-K data

Operating expense ratio (other)

No 10-K data

Operating margin (other)

No 10-K data

Other revenue (other)

No 10-K data

Participating providers (other)

No 10-Q data

Participating providers in network (other)

No 10-Q data

Pharmacies in network (other)

No 10-Q data

Pharmacy % of total revenues (other)

No 10-K data

Pharmacy Services facilities (other)

No 10-K data

Pharmacy Services net revenue increase (other)

No 10-K data

Pharmacy claims processed (other)

Pharmacy claims processed (PBM) (other)

No 10-Q data

Pharmacy network revenue (other)

No 10-K data

Pharmacy percent of total revenues (other)

No 10-K data

Pharmacy percentage of sales (other)

No 10-K data

Pharmacy percentage of total revenue (other)

No 10-K data

Pharmacy percentage of total sales (other)

No 10-K data

Pharmacy revenue % of net revenues (other)

No 10-Q data

Pharmacy revenue mix (other)

No 10-K data

Pharmacy sales (other)

No 10-Q data

Pharmacy sales as percent of total sales (other)

No 10-K data

Pharmacy sales mix (other)

No 10-K data

Pharmacy sales percentage (other)

No 10-K data

Pharmacy sales share (other)

No 10-Q data

Pharmacy services facilities (other)

No 10-K data

Pharmacy services locations (other)

No 10-K data

Pharmacy share of net sales (other)

No 10-K data

Pharmacy share of retail revenues (other)

No 10-Q data

Pharmacy share of revenue (other)

No 10-K data

Pharmacy share of revenues (other)

No 10-K data

Pharmacy share of sales (other)

Pharmacy share of segment revenue (other)

No 10-Q data

Pharmacy share of total revenue (other)

No 10-Q data

Pharmacy share of total revenues (other)

No 10-K data

Pharmacy share of total sales (other)

No 10-Q data

Planned store openings (other)

No 10-K data

Prescription files purchased (other)

No 10-Q data

Prescription volume (other)

No 10-K data

Prescription volume growth (other)

Prescription volume increase (other)

No 10-K data

Primary care medical clinics (other)

Private label products (other)

No 10-Q data

Private label share of front store sales (other)

No 10-Q data

Proprietary brand share of front store (other)

No 10-Q data

Provider network (other)

No 10-Q data

Retail Pharmacy Market Share (other)

No 10-Q data

Retail apothecary pharmacies (other)

No 10-K data

Retail drugstores closed (other)

No 10-K data

Retail drugstores relocated (other)

No 10-K data

Retail generic dispensing rate (other)

No 10-K data

Retail health care clinics (other)

No 10-K data

Retail health clinics (other)

No 10-Q data

Retail healthcare clinics (other)

No 10-Q data

Retail medical clinics (other)

No 10-K data

Retail net revenue increase (other)

No 10-K data

Retail network pharmacies (other)

No 10-K data

Retail pharmacy market share (other)

No 10-Q data

Retail pharmacy network (other)

Retail pharmacy network pharmacies (other)

Retail prescription market share (other)

No 10-Q data

Retail specialty pharmacy stores (other)

No 10-Q data

Revenue mix by product group (other)

No 10-Q data

Revenue per mail choice claim (other)

No 10-K data

Sales per square foot (other)

No 10-Q data

Same-store prescription volume (other)

No 10-K data

Same-store prescription volume growth (other)

No 10-K data

Specialty mail order pharmacies (other)

Specialty pharmacies (other)

No 10-K data

Star ratings membership (other)

No 10-K data

States of operation (other)

No 10-Q data

States with stores (other)

No 10-Q data

Stores acquired (other)

No 10-K data

Stores closed (other)

Stores opened (other)

Stores relocated (other)

No 10-K data

Third party % of pharmacy revenue (other)

Third party percent of pharmacy revenue (other)

No 10-K data

Third party percentage of pharmacy revenue (other)

No 10-K data

Third party percentage of pharmacy sales (other)

No 10-K data

Third party pharmacy revenue (other)

No 10-Q data

Third party pharmacy sales (other)

No 10-Q data

Third party pharmacy sales percentage (other)

No 10-K data

Third party prescription mix (other)

No 10-K data

Third party prescription sales (other)

No 10-Q data

Third party prescription sales as percent of pharmacy sales (other)

No 10-K data

Third party prescription sales mix (other)

No 10-K data

Third party sales mix (other)

No 10-K data

Third party share of pharmacy revenue (other)

No 10-K data

Third party share of pharmacy sales (other)

No 10-Q data

Third-party pharmacy revenue mix (other)

No 10-K data

Third-party pharmacy sales share (other)

No 10-Q data

Third-party prescription mix (other)

No 10-K data

Third-party prescription sales (other)

No 10-Q data

Third-party prescription sales mix (other)

No 10-K data

Third-party revenue mix (other)

No 10-K data

Third-party share of pharmacy revenue (other)

Third-party share of pharmacy sales (other)

Top 100 drugstore markets served (other)

No 10-Q data

Top 5 managed care providers (other)

No 10-Q data

Top market coverage (other)

No 10-Q data

Total prescription volume growth (other)

No 10-K data

U.S. retail market share (other)

No 10-Q data

U.S. retail pharmacy market share (other)

No 10-Q data

U.S. retail prescription market share (other)

No 10-Q data

US retail pharmacy market share (other)

No 10-Q data

US retail prescription market share (other)

No 10-Q data

Walk-in medical clinics (other)

Year 2000 incremental cost (other)

No 10-K data

Year 2000 remediation progress (other)

No 10-K data

LTC Patients (patients)

Medical membership (policies_in_force)

Prescriptions filled (prescriptions_filled)

COVID-19 Vaccines Administered (procedures)

Clinics (properties)

Participating providers (providers)

No 10-Q data

Same-store sales growth (same_store_sales)

Distribution center square footage (square_footage)

No 10-Q data

Stores (stores)

Medicare Part D beneficiaries (subscribers)

Pharmacy claims processed (transactions)

OTC Test Kits Sold (units_shipped)

No 10-Q data

Loyalty program cardholders (users)

Human capital disclosures. Workforce totals and demographics are point-in-time. Flow metrics use the year-to-date period for 10-Q and full year for 10-K. Workforce actions (RIFs, restructurings, acquisition-related changes) are listed in the table at the bottom.

Workforce Totals

No 10-Q data
No 10-Q data
No 10-Q data

Demographics

No 10-Q data
No 10-Q data
No 10-Q data
No 10-Q data

Workforce Breakdowns

No 10-Q data

HCM Metrics — Point-in-Time

No 10-Q data

HCM Metrics — Flow (Annual / YTD)

No 10-Q data

Workforce Actions

Period EndTypeStatusAffected% WorkforceAnnouncedExpected CompletionGeographySegment / FunctionChargeSourceNote
2025-12-31plant_closurecompleted2024-092025-12-31United StatesPharmacy & Consumer WellnessItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		221 retail stores closed during FY2025 under the enterprise-wide restructuring plan announced in Q3 2024. Across all activity the Company opened 87 locations, relocated 5 and closed 243 locations in 2025. The related $607M store impairment charge was recorded in fiscal 2024; no restructuring charge was recorded in FY2025. Affected employee count not disclosed.
2025-12-31restructuringcompleted2024-092025-12-31United StatesCorporateUSD 293 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Corporate workforce optimization component of the 2024 enterprise-wide restructuring program; severance charge was recorded in fiscal 2024, with $193M of severance payments made during FY2025. Program substantially complete as of 2025 year-end. Affected headcount not disclosed. Shares announcement date with the retail store closure action above.
2025-12-31acquisition_additioncompleted2025-052025-09-30Idaho, Oregon, WashingtonPharmacy & Consumer Wellnessbusiness_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Acquisition of prescription files of certain Rite Aid pharmacies plus certain Rite Aid stores for total consideration of $465M; closings completed in Q3 2025. Headcount added not disclosed.
2025-12-31divestiture_reductioncompleted2025-032025-12-31United StatesHealth ServicesUSD 288 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Substantial exit from the ACO REACH program (voluntary termination effective 2025-03-31) and divestiture of MSSP operations to Wellvana Health in March 2025. FY2025 pre-tax loss on Accountable Care assets of $288M comprises a $236M loss on the MSSP divestiture (including removal of $342M of intangibles and goodwill) and $52M of ACO REACH wind-down costs. Headcount not disclosed.
2025-12-31plant_closureannounced2025-092026United StatesHealth Services — Health Care Delivery (Oak Street Health)USD 83 (millions)MD&A
f5-10k / MiMo-V2.6-Flash-fp8-HTML		New Health Care Delivery management team presented strategy changes to the Board in September 2025: certain existing Oak Street Health clinics will close during 2026 and new clinic openings will be reduced. FY2025 charge of $83M covers long-lived asset write-downs plus expected severance and employee-related costs. Number of clinics and employees affected not disclosed.
2025-12-31othercompleted2025-09-222025-09-22United StatesPharmacy & Consumer Wellness — long-term care pharmacy (Omnicare)other
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Omnicare, LLC and certain subsidiaries voluntarily filed Chapter 11 on 2025-09-22 and were deconsolidated, removing their workforce from reported headcount. A $483M gain on deconsolidation was recorded; retained investment fair value was $0. Prior-year results were not material. Headcount not disclosed.
2025-12-31restructuringcompleted2024-09-302025-12-31United StatesCorporate/Other; Pharmacy & Consumer WellnessUSD 1,179 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0		2024 Restructuring Program finalized in Q3 2024. Charges included $293M for corporate workforce optimization (severance/employee-related costs) and $607M store impairment. Program substantially complete as of Dec 31, 2025. Employee count not explicitly disclosed in footnote.
2025-12-31plant_closurecompleted2024-09-302025-12-31United StatesPharmacy & Consumer WellnessItem_1_Business
f5-10k / Qwen3.6-27B-Q8_0		Closed 221 retail stores in 2025 in connection with the strategic review announced in Q3 2024. Total closures for the year were 243 (including 22 non-strategic). Employee count not disclosed.
2025-09-30plant_closureannounced2025-092026United StatesHealth Services — Health Care Delivery (Oak Street Health)USD 83 (millions)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Charge covers write-down of long-lived assets for planned 2026 closures of certain Oak Street Health clinics plus related severance and employee costs; strategy changes presented to the Board in September 2025; affected employee count not disclosed.
2025-09-30divestiture_reductioncompleted2025-032025-03United StatesHealth Services — Medicare Shared Savings Program (MSSP) operationsUSD 236 (millions)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML		MSSP operations divested to Wellvana Health, LLC in March 2025; $236M pre-tax loss includes removal of $342M of intangibles and goodwill; consideration not material; headcount removed not disclosed.
2025-09-30othercompleted2025-022025-03-31United StatesHealth Services — ACO REACH programUSD 52 (millions)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Company informed CMS in February 2025 of voluntary termination of substantially all ACO REACH participation effective March 31, 2025; $52M of wind-down costs recorded in the nine months ended September 30, 2025; headcount not disclosed.
2025-09-30othercompleted2025-09-222025-09-22United StatesPharmacy & Consumer Wellness — Omnicare long-term care pharmacyother
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Omnicare entities filed Chapter 11 on September 22, 2025 and were deconsolidated the same day, removing their workforce from consolidated reporting; a $483M gain on deconsolidation was recorded; headcount not disclosed.
2025-09-30acquisition_additioncompleted2025-05United States (Idaho, Oregon, Washington)Pharmacy & Consumer Wellnessbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Agreement reached May 2025 to acquire prescription files of certain Rite Aid pharmacies and operate certain Rite Aid stores for $465M total consideration; closings completed during Q3 2025 (exact date not disclosed); $285M of customer relationship intangibles recorded; headcount added not disclosed.
2025-09-30restructuringin_progress2025-09-302026-12-31United StatesHealth Services (Health Care Delivery)USD 83 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0		Health Care Delivery clinic closure charge related to write down of long-lived assets and associated severance for planned closure of certain Oak Street Health clinics in 2026.
2025-09-30restructuringcompleted2025-03-312025-03-31United StatesHealth ServicesUSD 288 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0		Loss on Accountable Care assets representing pre-tax loss on divestiture of MSSP operations and costs for winding down ACO REACH operations.
2025-09-30divestiture_reductioncompleted2025-09-222025-09-22United StatesPharmacy & Consumer WellnessMD&A
f5-10q / Qwen3.6-27B-Q8_0		Deconsolidation of Omnicare Entities following Chapter 11 bankruptcy filing. Employee count not disclosed.
2025-06-30restructuringin_progress2024-09-30United StatesEnterprise-wideMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Enterprise-wide restructuring plan finalized in Q3 2024 to streamline the organization; expected cost savings of over $500 million in 2025. No employee count, severance amount, or completion date disclosed in this filing.
2025-03-31restructuringin_progress2024-09-30United StatesEnterprise-wideMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Enterprise-wide restructuring plan finalized in Q3 2024; expected cost savings over $500M in 2025. No employee count or severance charge disclosed in this filing.
2025-03-31divestiture_reductioncompleted2025-03-312025-03-31United StatesHealth ServicesUSD 236 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		MSSP operations divested to Wellvana Health, LLC in March 2025; pre-tax loss of $236M including removal of $342M in intangibles and goodwill. No employee count disclosed.
2025-03-31divestiture_reductioncompleted2025-03-312025-03-31United StatesHealth ServicesUSD 236 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0		Divestiture of MSSP operations to Wellvana Health, LLC. Pre-tax loss of $236 million recorded. Employee count not disclosed.
2025-03-31restructuringcompleted2025-02-282025-03-31United StatesHealth ServicesUSD 11 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0		Voluntary termination of substantially all participation in ACO REACH program. Costs of $11 million incurred. Employee count not disclosed.
2025-03-31restructuringcompleted2025-03-312025-03-31United StatesCorporate/OtherUSD 6 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0		Office real estate optimization charges related to abandonment of leased real estate and right-of-use assets. Employee count not disclosed.
2024-12-31plant_closurecompleted2024-12-31United StatesPharmacy & Consumer WellnessItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		299 retail stores closed during 2024 as part of ongoing footprint optimization; part of prior ~900-store closure program announced in Q4 2021
2024-12-31plant_closureannounced2024-09-302025-12-31United StatesPharmacy & Consumer WellnessUSD 607 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		271 additional retail stores planned for closure in 2025; $607M store impairment charge recorded in Q3 2024 ($483M ROU assets, $124M PP&E)
2024-12-31restructuringin_progress2024-09-302025-12-31United StatesCorporate/OtherUSD 293 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Corporate workforce optimization costs including severance and employee-related costs under enterprise-wide restructuring plan; $88M paid during 2024; employees affected count not disclosed; plan expected substantially complete by end of 2025
2024-12-31restructuringin_progress2024-09-302025-12-31United StatesCorporate/Other and Pharmacy & Consumer WellnessUSD 269 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Other asset impairments from discontinuation of certain non-core assets including virtual care services and compounding infusion pharmacies/branches
2024-12-31restructuringin_progress2024-09-302025-12-31United StatesCorporate/Other; Pharmacy & Consumer WellnessUSD 1,179 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0		Enterprise-wide restructuring plan finalized in Q3 2024. Includes $607M store impairment, $293M corporate workforce optimization (severance/employee-related), $269M other asset impairments, and $10M stock-based comp. Filer does not disclose specific employee headcount affected, only financial charges. Corporate workforce optimization expected to be substantially complete by end of 2025.
2024-12-31plant_closurecompleted2021-10-012024-12-31United StatesPharmacy & Consumer WellnessItem_1_Business
f5-10k / Qwen3.6-27B-Q8_0		Strategic review completed in Q4 2021 to close approx. 900 retail stores between 2022 and 2024. As of Dec 31, 2024, approx. 900 stores closed. No specific employee count disclosed.
2024-12-31plant_closureannounced2024-09-302025-12-31United StatesPharmacy & Consumer WellnessItem_1_Business
f5-10k / Qwen3.6-27B-Q8_0		Strategic review in Q3 2024 determined plans to close an additional 271 retail stores in 2025. No specific employee count disclosed.
2024-09-30restructuringin_progress2024-09-302025-12-31United StatesCorporate/OtherUSD 293 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Corporate workforce optimization costs including severance and employee-related costs; no employee count disclosed. Program expected substantially complete by end of 2025.
2024-09-30plant_closureannounced2024-09-302025-12-31United StatesPharmacy & Consumer WellnessUSD 607 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Plans to close 271 retail stores in 2025; store impairment charge of $607M ($483M ROU assets, $124M PP&E). No employee count disclosed.
2024-09-30restructuringin_progress2024-09-302025-12-31United StatesCorporate/Other and Pharmacy & Consumer WellnessUSD 269 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Other asset impairments from discontinuing non-core assets including certain virtual care services and compounding infusion pharmacies/branches. No employee count disclosed.
2024-09-30restructuringin_progress2024-09-302025-12-31United StatesCorporateUSD 293 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Corporate workforce optimization costs, including severance and employee-related costs. Employee count not disclosed.
2024-09-30plant_closureannounced2024-09-302025-12-31United StatesPharmacy & Consumer WellnessUSD 607 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Plans to close 271 retail stores in 2025. Charge consists of write-down of operating lease right-of-use assets and property and equipment. Employee count not disclosed.
2024-09-30restructuringcompleted2024-09-302024-09-30United StatesCorporate/Other and Pharmacy & Consumer WellnessUSD 269 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Discontinuation of certain non-core assets, including virtual care services and compounding infusion pharmacies. Employee count not disclosed.
2024-06-30restructuringcompleted2023-04-01United StatesCorporate/OtherUSD 496 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0		Charge recorded in Q2 2023 for enterprise-wide restructuring plan to streamline organization and terminate certain transformation initiatives. No charge in current period.
2024-06-30restructuringcompleted2023-01-01United StatesPharmacy & Consumer WellnessUSD 349 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0		Loss on assets held for sale related to write-down of LTC business in Q1 2023. No charge in current period.
2023-12-31restructuringcompleted2023-06-302023-12-31United StatesCorporate/OtherUSD 507 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Enterprise-wide plan developed in Q2 2023; $344M severance, $152M asset impairment, $11M stock-based comp; substantially complete at year-end; headcount not disclosed
2023-12-31plant_closurein_progress2021-11-172024-12-31United StatesPharmacy & Consumer WellnessItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Multi-year program to close ~900 retail stores 2022-2024; ~318 stores closed during 2023; ~600 cumulative closed as of 2023-12-31; associated headcount not disclosed
2023-12-31acquisition_additioncompleted2023-03-292023-03-29United StatesHealth Servicesbusiness_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Acquisition of Signify Health completed 2023-03-29; headcount added not disclosed
2023-12-31acquisition_additioncompleted2023-05-022023-05-02United StatesHealth Servicesbusiness_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Acquisition of Oak Street Health completed 2023-05-02; headcount added not disclosed
2023-12-31restructuringcompleted2023-04-302023-12-31United StatesCorporate/OtherUSD 507 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0		Enterprise-wide restructuring plan developed in Q2 2023 to streamline organization. Includes severance, asset impairments, and stock-based compensation. Program substantially complete as of Dec 31, 2023. Employee count not explicitly disclosed in footnote.
2023-12-31acquisition_additioncompleted2023-03-292023-03-29United StatesHealth Servicesbusiness_combinations_footnote
f5-10k / Qwen3.6-27B-Q8_0		Acquisition of Signify Health. Headcount not explicitly disclosed.
2023-12-31acquisition_additioncompleted2023-05-022023-05-02United StatesHealth Servicesbusiness_combinations_footnote
f5-10k / Qwen3.6-27B-Q8_0		Acquisition of Oak Street Health. Headcount not explicitly disclosed.
2023-09-30restructuringin_progress2023-04-012023-12-31United StatesCorporate/OtherUSD 507 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Enterprise-wide plan developed in Q2 2023; $496M pre-tax charge in Q2 ($344M severance, $152M asset impairment) plus $11M stock-based compensation charge in Q3 2023. Severance accrual recorded in accrued expenses; $58M of severance payments made in Q3. No employee count disclosed.
2023-09-30acquisition_additioncompleted2023-03-292023-03-29United StatesHealth Servicesbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Acquisition of Signify Health closed 2023-03-29 for $7,353M consideration; headcount added not disclosed.
2023-09-30acquisition_additioncompleted2023-05-022023-05-02United StatesHealth Servicesbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Acquisition of Oak Street Health closed 2023-05-02 for $9,668M consideration; headcount added not disclosed. Acquired workforce referenced only qualitatively as part of goodwill rationale.
2023-09-30restructuringin_progress2023-06-302023-12-31Enterprise-wideCorporate/OtherUSD 507 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Enterprise-wide restructuring plan to streamline organization and improve efficiency. Includes $344M severance/employee costs and $152M asset impairments recorded in Q2, plus $11M stock-based compensation in Q3. Employee count not disclosed.
2023-09-30acquisition_additioncompleted2023-05-02United StatesHealth Servicesbusiness_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0		Acquisition of Oak Street Health. Headcount added not explicitly disclosed.
2023-09-30acquisition_additioncompleted2023-03-29United StatesHealth Servicesbusiness_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0		Acquisition of Signify Health. Headcount added not explicitly disclosed.
2023-06-30restructuringin_progress2023-06-302023-12-31United StatesCorporate/OtherUSD 496 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Enterprise-wide plan includes $344M severance and $152M asset impairments; no employee count disclosed. Severance recorded in accrued expenses; no payments made during Q2 2023.
2023-06-30restructuringin_progress2023-06-302023-12-31Enterprise-wideCorporate/OtherUSD 496 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Enterprise-wide restructuring plan to streamline organization and improve efficiency. Charge includes $344M severance/employee-related costs and $152M asset impairments. Employee count not disclosed.
2023-03-31acquisition_additioncompleted2023-03-292023-03-29United StatesHealth Servicesbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Acquired 100% of Signify Health for $7,353M consideration; goodwill attributed partly to assembled workforce. No employee count disclosed.
2023-03-31acquisition_additionannounced2023-05-022023-05-02United StatesHealth Servicesbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Subsequent-event acquisition completed May 2, 2023, funded partly by $5.0B term loan; no employee count disclosed.
2022-12-31plant_closurein_progress2021-11-172024-12-31United StatesRetail/LTCItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Approximately 300 stores closed during 2022; store-level employee counts not disclosed. Prior-year store impairment charge of ~$1.4B relates to this program
2022-12-31divestiture_reductioncompleted2022-06-302022-06-30United StatesHealth Care Benefitsother
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Headcount removed through divestiture not disclosed
2022-12-31divestiture_reductioncompleted2022-11-302022-11-30United StatesHealth Care Benefitsother
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Headcount removed through divestiture not disclosed
2022-12-31divestiture_reductioncompleted2022-03-312022-06-30ThailandHealth Care BenefitsUSD 41 (millions)other
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Loss on assets held for sale of $41 million recorded in Q1 2022; employee headcount not disclosed
2022-12-31acquisition_additionannounced2022-09-022023-06-30United StatesHealth Care Benefitsother
f5-10k / MiMo-V2.6-Flash-fp8-HTML		DOJ second request received 2022-10-19; expected close Q2 2023; headcount addition not disclosed
2022-12-31acquisition_additionannounced2023-02-072023-12-31United StatesHealth Care Benefitssubsequent_events
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Announced after fiscal year-end (2023-02-07); expected to close in 2023; headcount addition not disclosed
2022-12-31plant_closurein_progress2021-11-172024-12-31United StatesRetail/LTCUSD 1,358 (millions)Item 1. Business - Community Location Development
f5-10k / Qwen3.6-27B-Q8_0		Announced closure of approximately 900 retail stores between 2022 and 2024. Approximately 300 stores closed in 2022. Charge relates to store impairments recorded in 2021.
2022-03-31divestiture_reductionin_progress2022-03-312022-06-30ThailandHealth Care Benefits — Commercial BusinessUSD 41 (millions)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Agreement reached in March 2022 to sell the Thailand business; $41M loss on assets held for sale recorded. No headcount affected disclosed.
2022-03-31divestiture_reductionannounced2022-04-02United StatesHealth Care Benefits — Payflexsubsequent_events
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Agreement reached April 2, 2022 to sell the Payflex business; no headcount affected or charge disclosed.
2021-12-31plant_closureannounced2021-11-172024-12-31United StatesRetail/LTCUSD 1,358 (millions)MD&A
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Board authorized closing approximately 900 stores over three years (about 300 per year, 2022-2024) as part of a retail format strategy review. Charge is a Q4 2021 impairment of operating lease ROU assets (~$1.1B) and property/equipment ($261M), not severance; no employee-impact count disclosed.
2021-12-31plant_closurecompleted2021-12-31United StatesRetail/LTCMD&A
f5-10k / MiMo-V2.6-Flash-fp8-HTML		81 stores closed during 2021 (Item 1 narrative states approximately 80 locations closed); no associated workforce count or charge disclosed. Separate from the announced 900-store program.
2021-12-31plant_closureannounced2021-11-172024-12-31United StatesRetail/LTCUSD 1,358 (millions)Item_1_Business
f5-10k / Qwen3.6-27B-Q8_0		Board authorized closing of approximately 900 retail stores over three years (2022-2024). Charge relates to write-down of lease right-of-use assets and property/equipment. Employee count not explicitly disclosed.
2020-12-31plant_closurecompletedUnited StatesRetail/LTCItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Same program also opened approximately 55 new locations, relocated approximately 20 and converted approximately 600 to HealthHUB format; associated headcount impact not disclosed
2020-12-31divestiture_reductioncompleted2020-07-312020-07-31United StatesHealth Care Benefits (Workers' Compensation business)other
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Pre-tax gain of $269 million recorded; headcount transferred with the business not disclosed
2019-12-31plant_closurecompleted2019-03-312019-06-30United StatesRetail/LTCUSD 135 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		First-quarter 2019 review identified 46 underperforming retail pharmacy stores for closure in Q2 2019; charge primarily operating lease right-of-use asset impairments. Announcement date stated only at quarter level. Employees affected not disclosed.
2019-12-31plant_closureannounced2019-09-302020-03-31United StatesRetail/LTCUSD 96 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Third-quarter 2019 annual budgeting review identified an additional 22 underperforming retail pharmacy stores for closure during Q1 2020; charge primarily operating lease right-of-use asset impairments. Announcement date stated only at quarter level. Employees affected not disclosed.
2019-12-31divestiture_reductioncompleted2019-07-012019-07-01BrazilRetail/LTCUSD 205 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Sale of Drogaria Onofre Ltda., which operated 50 retail pharmacy stores, for an immaterial amount; $205 million pre-tax loss primarily reflecting elimination of cumulative translation adjustment. Headcount removed not disclosed.
2019-12-31plant_closurecompleted2019-06-302019-06-30United StatesRetail/LTCUSD 135 (millions)MD&A
f5-10k / Qwen3.6-27B-Q8_0		Closure of 46 underperforming retail pharmacy stores in Q2 2019. Charge primarily related to operating lease right-of-use asset impairment.
2019-12-31plant_closureannounced2019-09-302020-03-31United StatesRetail/LTCUSD 96 (millions)MD&A
f5-10k / Qwen3.6-27B-Q8_0		Announced closure of 22 underperforming retail pharmacy stores in Q3 2019, planned for Q1 2020. Charge primarily related to operating lease right-of-use asset impairment.
2019-12-31divestiture_reductioncompleted2019-07-012019-07-01BrazilRetail/LTCUSD 205 (millions)MD&A
f5-10k / Qwen3.6-27B-Q8_0		Sale of Brazilian subsidiary Drogaria Onofre Ltda. ('Onofre'), which operated 50 retail pharmacy stores. Loss primarily relates to elimination of cumulative translation adjustment.
2019-09-30plant_closurecompleted2019-03-312019-06-30United StatesRetail/LTCUSD 135 (millions)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Closure of 46 underperforming retail pharmacy stores decided in Q1 2019; charge primarily for operating lease right-of-use asset impairments. No employee count disclosed.
2019-09-30plant_closureannounced2019-09-302020-03-31United StatesRetail/LTCUSD 96 (millions)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Closure of 22 additional underperforming retail pharmacy stores planned for Q1 2020, identified during Q3 2019 annual budgeting. Charge recorded in Q3 2019. No employee count disclosed.
2019-09-30divestiture_reductioncompleted2019-07-012019-07-01BrazilRetail/LTCUSD 205 (millions)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Sale of Drogaria Onofre Ltda., which operated 50 retail pharmacy stores. Loss primarily reflects elimination of cumulative translation adjustment. No employee count disclosed.
2019-09-30plant_closurecompleted2019-03-312019-06-30United StatesRetail/LTCUSD 135 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0		Closure of 46 underperforming retail pharmacy stores in Q2 2019. Charge primarily related to operating lease right-of-use asset impairment.
2019-09-30plant_closureannounced2019-09-302020-03-31United StatesRetail/LTCUSD 96 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0		Closure of 22 underperforming retail pharmacy stores planned for Q1 2020. Charge primarily related to operating lease right-of-use asset impairment.
2019-09-30divestiture_reductioncompleted2019-07-012019-07-01BrazilRetail/LTCUSD 205 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0		Sale of Brazilian subsidiary Drogaria Onofre Ltda. Loss primarily relates to elimination of cumulative translation adjustment.
2019-06-30plant_closurecompleted2019-06-30United StatesRetail/LTCUSD 135 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Closure of 46 underperforming retail pharmacy stores in Q2 2019; charge primarily reflects operating lease ROU asset impairments. No employee count disclosed.
2019-06-30divestiture_reductionannounced2019-07-012019-07-01BrazilRetail/LTCUSD 200 (millions)subsequent_events
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Sale of Drogaria Onofre Ltda. (50 retail pharmacy stores) on July 1, 2019 for an immaterial amount; expected ~$200M loss in Q3 2019, primarily elimination of cumulative translation adjustment. No employee count disclosed.
2019-06-30plant_closurein_progress2019-06-302019-06-30United StatesRetail/LTCUSD 135 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0		Company determined it would close 46 underperforming retail pharmacy stores during the second quarter of 2019. Recorded $135 million store rationalization charge primarily related to operating lease right-of-use asset impairment. Employee count affected not disclosed.
2019-03-31plant_closureannounced2019-03-312019-06-30United StatesRetail/LTCUSD 135 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Company determined to close 46 underperforming retail pharmacy stores in Q2 2019; charge primarily for operating lease right-of-use asset impairments. No employee count disclosed.
2019-03-31plant_closureannounced2019-03-312019-06-30United StatesRetail/LTCUSD 135 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0		Company determined it would close 46 underperforming retail pharmacy stores during the second quarter of 2019. Recorded $135 million store rationalization charge primarily related to operating lease right-of-use asset impairment charges. Employee count affected not disclosed.
2018-12-31acquisition_additioncompleted2017-12-032018-11-28United StatesHealth Care Benefits (new reportable segment); Pharmacy Services; Retail/LTC; Corporate/Otherbusiness_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Aetna Inc. acquired 2018-11-28 for ~$70bn (~$78bn including assumed debt); added the Health Care Benefits segment. Aetna headcount added is not quantified in the filing. Aetna represented 21% of consolidated total assets and 3% of FY2018 revenues post-close.
2018-12-31divestiture_reductioncompleted2018-01-02United StatesRetail/LTC — RxCrossroads commercialization servicesUSD 86 (millions)MD&A
f5-10k / MiMo-V2.6-Flash-fp8-HTML		RxCrossroads subsidiary sold to McKesson Corporation for $725 million on 2018-01-02; $86 million pre-tax loss on divestiture recorded in 2018. Employee count transferred not disclosed.
2018-12-31plant_closurecompleted2018-12-31United StatesRetail/LTC — retail drugstoresMD&A
f5-10k / MiMo-V2.6-Flash-fp8-HTML		27 retail stores closed during 2018 (Item 1 narrative states approximately 30 closures). Filing states no significant facility closing charges were recognized in 2018; associated workforce reduction not quantified.
2018-12-31acquisition_additioncompleted2018-11-282018-11-28United StatesHealth Care BenefitsItem_1_Business
f5-10k / Qwen3.6-27B-Q8_0		Acquisition of Aetna Inc. completed on November 28, 2018. Specific headcount added not disclosed in this filing.
2018-12-31divestiture_reductioncompleted2018-11-302018-11-30United StatesPharmacy ServicesItem_1_Business
f5-10k / Qwen3.6-27B-Q8_0		Sale of Aetna's standalone Medicare Part D prescription drug plans to WellCare completed on November 30, 2018. Specific headcount removed not disclosed.
2018-12-31plant_closurecompleted2018-12-312018-12-31United StatesRetail/LTCItem_1_Business
f5-10k / Qwen3.6-27B-Q8_0		Company closed approximately 30 retail locations during 2018. Specific employee count not disclosed.
2018-06-30divestiture_reductioncompleted2018-01-02Retail/LTCUSD 86 (millions)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML		RxCrossroads sold to McKesson for $725M, completed 2018-01-02 (within YTD period, before Q2); $86M pre-tax loss recorded in Retail/LTC. Filing discloses no headcount impact. Announcement date not stated in this filing.
2018-03-31divestiture_reductioncompleted2018-01-022018-01-02United StatesRetail/LTC (RxCrossroads commercialization services)USD 86 (millions)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML		RxCrossroads sold to McKesson for $725 million; $86 million pre-tax loss recorded in operating expenses. Number of employees affected not disclosed.
2018-03-31acquisition_additionannounced2017-12-03United StatesEnterprise (Aetna Inc.)USD 40 (millions)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Pending merger ($69bn equity value); $40 million of acquisition-related transaction and integration costs in Corporate Segment for the quarter. No headcount addition disclosed; DOJ second request received 2018-02-01.
2017-12-31restructuringcompleted2016-122017-12-31United StatesRetail/LTCUSD 215 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Enterprise streamlining initiative: 71 underperforming retail stores closed during FY2017; charges primarily the present value of noncancelable lease obligations. Employees affected not disclosed. Item 1 separately reports 81 total store closures in 2017 (all causes).
2017-12-31divestiture_reductioncompleted2018-01-02United StatesRetail/LTC (RxCrossroads reporting unit)USD 9 (millions)subsequent_events
f5-10k / MiMo-V2.6-Flash-fp8-HTML		RxCrossroads commercialization business sold to McKesson for $725 million on 2018-01-02 (subsequent to fiscal year-end); $9M divestiture transaction costs recorded in Corporate segment during FY2017; $181M cumulative goodwill impairment recorded in FY2017. Headcount not disclosed.
2017-12-31acquisition_additioncompleted2017-11-302017-11-30United StatesPharmacy Servicesbusiness_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Wellpartner acquired for approximately $380 million; two specialty pharmacies (Oregon and Kentucky). Headcount added not disclosed; Bluegrass Pharmacy subsequently classified as held for sale/discontinued operations.
2017-12-31acquisition_additionannounced2017-12-03United StatesEnterprise (Aetna Inc.)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Merger agreement signed 2017-12-03; projected to close in second half of 2018, subject to shareholder and regulatory approvals. $34M transaction costs recorded in FY2017. Aetna headcount not disclosed; $2.1B termination fee applies if not completed.
2017-12-31plant_closurecompleted2016-12-012017-12-31United StatesRetail/LTCUSD 215 (millions)MD&A
f5-10k / Qwen3.6-27B-Q8_0		Closure of 71 retail stores in connection with enterprise streamlining initiative. Charges of $215 million recorded in operating expenses. Employee count not explicitly disclosed.
2017-12-31restructuringin_progressUSD 215,000,000 (absolute)restructuring_footnote
f5-10k / no-ai-xblr
2017-12-31restructuringin_progressOperating Income Loss [Member] / Retail L T C Segment [Member]USD 215,000,000 (absolute)restructuring_footnote
f5-10k / no-ai-xblr
2017-09-30plant_closurein_progress2016-12-312017-12-31United StatesRetail/LTCUSD 211 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Enterprise streamlining initiative announced December 2016; 68 stores closed YTD through 2017-09-30 (5 in Q3) out of ~70 planned for FY2017. Charges are primarily lease obligation provisions; no employee counts disclosed. Additional ~$9M charge expected in Q4 2017.
2017-09-30divestiture_reductionannounced2017-11-062018-03-31United StatesRetail/LTC — RxCrossroadsother
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Definitive agreement to sell RxCrossroads to McKesson for $735M signed 2017-11-06 (subsequent event); expected close Q1 2018. No headcount associated with the divestiture disclosed.
2017-09-30plant_closurein_progress2016-12-012017-12-31United StatesRetail/LTCUSD 211 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Company announced intention to close approx. 70 underperforming stores. 68 closed in nine months ended Sept 30, 2017. Charges primarily for noncancelable lease obligations. Employee count not disclosed.
2017-09-30restructuringin_progressUSD 211,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2017-09-30restructuringin_progressOperating Income Loss [Member] / Retail L T C Segment [Member]USD 211,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2017-06-30plant_closurein_progress2016-122017-12-31United StatesRetail/LTCUSD 205 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Enterprise streamlining initiative announced December 2016 to close roughly 70 underperforming retail stores during 2017; 63 stores closed in the six months ended June 30, 2017 (3 in Q2) with $205M of charges YTD ($6M in Q2), primarily lease obligation provisions; about $15M of additional charges expected for the remainder of 2017. Employees affected not disclosed; charges are not severance-specific.
2017-06-30plant_closurein_progress2016-12-012017-12-31United StatesRetail/LTCUSD 205 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Company announced intention to close approx. 70 underperforming stores. 63 closed in six months ended June 30, 2017. Charges primarily for noncancelable lease obligations. Employee count not disclosed.
2017-06-30restructuringin_progressUSD 205,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2017-06-30restructuringin_progressOperating Income Loss [Member] / Retail L T C Segment [Member]USD 205,000,000 (absolute)restructuring_footnote
f5-10q / no-ai-xblr
2017-03-31plant_closurein_progress2016-12-012017-12-31United StatesRetail/LTCUSD 199 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Enterprise streamlining initiative announced December 2016; 60 stores closed in Q1 2017 of approximately 70 planned for full-year 2017. Charge is primarily the present value of noncancelable lease obligations extending through 2039; no employee count disclosed. Approximately $20 million of additional charges expected for the remainder of 2017.
2017-03-31plant_closurecompleted2016-12-012017-12-31United StatesRetail/LTCUSD 199 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Closed 60 retail stores in Q1 2017 as part of enterprise streamlining initiative. Charge primarily comprised of provision for present value of noncancelable lease obligations. Employee count not disclosed.
2016-12-31plant_closureannounced2016-12-312017-12-31United StatesRetail/LTC Segment — retail drugstoresUSD 225 (millions)MD&A
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Company intends to close approximately 70 retail stores during 2017 with an expected charge of about $225 million for remaining lease obligations; a $34 million asset impairment related to these planned closures was recorded in 2016. No employee count disclosed.
2016-12-31plant_closurecompleted2016-12-31United StatesRetail/LTC Segment — retail drugstoresItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		46 retail stores closed during 2016 (MD&A store development table shows 47 closed stores, excluding relocations). No associated headcount or charge disclosed.
2016-12-31acquisition_additioncompleted2015-08-182015-08-18United StatesRetail/LTC and Pharmacy ServicesItem 1. Business
f5-10k / Qwen3.6-27B-Q8_0		Acquisition of Omnicare completed in Aug 2015; headcount not explicitly quantified in HC section.
2016-12-31acquisition_additioncompleted2015-12-162015-12-16United StatesRetail/LTCItem 1. Business
f5-10k / Qwen3.6-27B-Q8_0		Acquisition of Target pharmacies and clinics completed Dec 2015; headcount not explicitly quantified in HC section.
2015-12-31acquisition_additioncompleted2015-05-202015-08-18United StatesRetail/LTC (long-term care) and Pharmacy Services (specialty)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Acquired Omnicare for $9.6 billion plus assumed debt; acquired headcount not disclosed. Omnicare results included $2.6 billion of net revenues from Aug 18 to Dec 31, 2015; transaction and integration costs of $156 million recorded in Corporate Segment plus $70 million transaction costs.
2015-12-31acquisition_additioncompleted2015-12-162015-12-16United States (47 states)Retail/LTC — pharmacies and clinicsbusiness_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Acquired 1,672 Target pharmacies and 79 clinics for approximately $1.9 billion plus up to $50 million contingent consideration; acquired employee headcount not disclosed. Approximately $26 million of transaction costs expensed.
2015-12-31plant_closurecompleted2015-12-31United StatesRetail/LTC — retail drugstoresItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		31 stores closed during 2015 per Item 1; the MD&A store development table shows 34 closed stores for 2015 (broader scope including onsite, specialty and Target formats). Associated workforce reduction not quantified.
2015-12-31acquisition_additioncompleted2015-08-182015-08-18United StatesRetail/LTC and Pharmacy ServicesItem 1. Business
f5-10k / Qwen3.6-27B-Q8_0		Acquired Omnicare on Aug 18, 2015. Specific headcount not disclosed in text, but operations added to Retail/LTC and Pharmacy Services segments.
2015-12-31acquisition_additioncompleted2015-12-162015-12-16United StatesRetail/LTCItem 1. Business
f5-10k / Qwen3.6-27B-Q8_0		Acquired pharmacy and clinic businesses of Target on Dec 16, 2015. Specific headcount not disclosed in text.
2015-09-30acquisition_additioncompleted2015-08-182015-08-18United StatesRetail/LTC; Pharmacy Servicesbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		CVS Health acquired Omnicare on 2015-08-18 for $9.6B cash plus ~$3.1B assumed debt. Employee headcount added through the acquisition is not disclosed. Omnicare's LTC operations (113 spoke pharmacies, 32 hub pharmacies) and specialty pharmacy business were integrated. Severance and accelerated stock-based compensation for terminated Omnicare executives were incurred but no employee count is given.
2015-09-30othercompletedUnited StatesRetail/LTC (Omnicare LTC operations)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Post-acquisition terminations of Omnicare executives resulted in $38M of accelerated stock-based compensation in Q3 2015. Number of executives terminated is not disclosed.
2015-09-30acquisition_additioncompleted2015-08-18United StatesRetail/LTC; Pharmacy ServicesUSD 9,645 (millions)business_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0		Acquired 100% of Omnicare, Inc. for $9.6 billion. Headcount not explicitly disclosed. Includes LTC operations and specialty pharmacy business.
2014-12-31acquisition_additioncompleted4,6002014-01-162014-01-16United StatesPharmacy Servicesbusiness_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Coram acquired 2014-01-16 for ~$2.1B cash; approximately 4,600 employees, including ~600 nurses and ~250 dietitians, across 84 branches and six centers of excellence.
2014-12-31plant_closurecompleted2014-12-31United StatesRetail PharmacyItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		22 retail stores closed during 2014 (store development table in Exhibit 13 shows 23 closures); no associated headcount or charge disclosed.
2014-12-31acquisition_additioncompleted4,6002014-01-162014-01-16United StatesPharmacy Servicesbusiness_combinations_footnote
f5-10k / Qwen3.6-27B-Q8_0		Acquisition of Coram LLC and subsidiaries included approximately 4,600 employees.
2014-09-30acquisition_additioncompleted4,6002014-01-16United StatesPharmacy Servicesbusiness_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0		Acquired Coram LLC, which has approximately 4,600 employees, including approximately 600 nurses and 250 dietitians.
2014-06-30acquisition_additioncompleted4,6002014-01-162014-01-16United StatesPharmacy Servicesbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Acquired 100% of Coram LLC for ~$2.1B cash plus ~$0.1B contingent consideration. Disclosed workforce of approximately 4,600 employees, including ~600 nurses and ~250 dietitians, across 84 branches and six centers of excellence. Acquisition costs of $14M expensed in the six months ended June 30, 2014. Acquisition closed in Q1 2014 but disclosed in this filing's business combination footnote.
2014-06-30acquisition_additioncompleted4,6002014-01-16United StatesPharmacy Servicesbusiness_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0		Acquired Coram LLC, which has approximately 4,600 employees, including approximately 600 nurses and 250 dietitians.
2014-03-31acquisition_additioncompleted4,6002014-01-16United StatesPharmacy Services Segmentbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Approximately 4,600 employees acquired, including roughly 600 nurses and 250 dietitians, across 84 branch locations and six centers of excellence; results included in Pharmacy Services Segment from 2014-01-16.
2014-03-31acquisition_additioncompleted4,6002014-01-16United StatesPharmacy Servicesbusiness_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0		Acquisition of Coram LLC included approximately 4,600 employees, including approximately 600 nurses and 250 dietitians.
2013-12-31plant_closurecompleted2013-12-31United StatesRetail PharmacyMD&A
f5-10k / MiMo-V2.6-Flash-fp8-HTML		MD&A store development table reports 19 closed stores in 2013; Item 1 states 13 stores closed during 2013. No associated headcount or charge disclosed.
2013-12-31acquisition_additioncompleted4,6002014-01-162014-01-16United StatesPharmacy ServicesUSD 2,100 (millions)subsequent_events
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Acquisition of Coram completed 2014-01-16, after fiscal year-end; approximately 4,600 employees including about 600 nurses and 250 dietitians. Purchase price approximately $2.1 billion; charge value reflects purchase price, not a severance charge.
2012-03-31plant_closurecompletedUnited StatesRetail PharmacyMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		During Q1 2012 the company closed seven retail drugstores and one onsite pharmacy (and opened 32 new drugstores, relocated 40). No associated workforce reduction count or charge disclosed.
2011-12-31acquisition_additioncompleted2011-04-292011-04-29United StatesPharmacy Services (Medicare Part D)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Acquisition of the Universal American Corp. Medicare prescription drug business for approximately $1.3 billion; headcount added not disclosed.
2011-12-31divestiture_reductioncompleted2011-11-012011-11-01United StatesPharmacy Services (TheraCom)discontinued_operations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Sale of TheraCom, L.L.C. to AmerisourceBergen for $250 million; headcount removed not disclosed. Results reclassified to discontinued operations for all periods.
2011-12-31plant_closurecompleted2011-12-31United StatesRetail PharmacyItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Item 1 states 16 retail stores closed during 2011; the MD&A store development table shows 22 closed stores for the same year. No associated workforce reduction quantified by the filer.
2011-09-30acquisition_additioncompleted2011-04-292011-04-29United StatesPharmacy ServicesUSD 1,300 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Acquisition of the UAM Medicare Part D business for approximately $1.3 billion; purchase price allocation is preliminary. No employee count disclosed for the acquired workforce.
2011-09-30divestiture_reductioncompleted2011-09-262011-11-01United StatesPharmacy ServicesUSD 250 (millions)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Sale of TheraCom, L.L.C. to AmerisourceBergen for $250 million, completed November 1, 2011 (subsequent to quarter end). TheraCom had approximately $0.1 billion of current assets and $0.1 billion of current liabilities at September 30, 2011; no headcount disclosed.
2011-09-30restructuringin_progressUnited StatesPharmacy ServicesMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		MD&A cites nine-month costs associated with changes designed to streamline the Pharmacy Services segment; no employee counts, severance amounts, or announcement dates disclosed.
2011-06-30acquisition_additioncompleted2011-04-292011-04-29United StatesPharmacy Servicesbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Acquisition of Universal American Corp.'s Medicare prescription drug business (Community CCRx plan) for approximately $1.3 billion; fair value of assets acquired $2.4B and liabilities assumed $1.1B. No employee headcount added disclosed.
2011-06-30plant_closurecompleted2011-06-30United StatesRetail Pharmacy / Pharmacy ServicesMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		During the six months ended June 30, 2011 the company closed 14 retail drugstores, two retail specialty pharmacy stores, one retail apothecary pharmacy store and five specialty mail order pharmacies. No associated workforce reduction figure disclosed.
2010-12-31plant_closurecompleted2010-12-31United StatesRetail PharmacyMD&A
f5-10k / MiMo-V2.6-Flash-fp8-HTML		MD&A store development table reports 27 stores closed during 2010; Item 1 narrative states 22 stores closed. No associated headcount or severance disclosed
2010-12-31acquisition_additionannounced2010-122011-06-30United StatesPharmacy ServicesUSD 1,250 (millions)subsequent_events
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Agreement to acquire Universal American Corp.'s Medicare Part D business for approximately $1.25 billion announced December 2010; pending regulatory and shareholder approvals, expected to close by end of Q2 2011. No headcount disclosed
2009-12-31plant_closurecompleted2009-12-31United StatesRetail PharmacyMD&A
f5-10k / MiMo-V2.6-Flash-fp8-HTML		MD&A store development table shows 82 stores closed during 2009; Item 1 states 76 retail pharmacy stores closed during 2009. Associated employee reductions are not quantified anywhere in the filing.
2009-12-31plant_closureannounced2010-04United StatesPharmacy Services — FDA-regulated repackaging facility, Gurnee, Illinoisother
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Filing states intent to close the Gurnee, Illinois repackaging facility in April 2010; no announcement date or affected-employee count disclosed.
2009-12-31acquisition_additioncompleted2009-12-302009-12-30United StatesPharmacy Services — genetic benefit management (Generation Health, Inc.)USD 34 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Acquired approximately 60% interest for approximately $34 million cash plus put rights to remaining noncontrolling shareholders (redeemable noncontrolling interest fair value $37 million). Headcount added through the acquisition is not disclosed; charge shown is purchase consideration, not a severance charge.
2009-09-30plant_closurecompletedUnited StatesRetail Pharmacy / Pharmacy ServicesMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		During the nine months ended 2009-09-30 the company closed 70 retail pharmacy stores, 8 specialty pharmacy stores and 1 mail order pharmacy; no associated employee counts or severance charges disclosed. Also opened 155 new retail stores and relocated 101 retail and 2 specialty stores.
2009-06-30plant_closurecompletedUnited StatesRetail PharmacyMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Closed 64 retail pharmacy stores during six months ended June 30, 2009. No associated employee count or charge disclosed.
2009-06-30plant_closurecompletedUnited StatesPharmacy ServicesMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Closed 7 specialty pharmacy stores during six months ended June 30, 2009. No associated employee count or charge disclosed.
2009-06-30plant_closurecompletedUnited StatesPharmacy ServicesMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Closed 1 mail order pharmacy during six months ended June 30, 2009. No associated employee count or charge disclosed.
2009-03-31acquisition_additioncompleted2008-10-20United StatesRetail Pharmacy; Pharmacy ServicesMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Acquisition of Longs Drug Stores Corporation (529 retail drug stores), RxAmerica LLC and related assets effective 2008-10-20; added approximately $1.4 billion of net revenues in Q1 2009. No employee headcount added through the acquisition is disclosed in this filing.
2009-03-31plant_closurecompletedUnited StatesRetail Pharmacy; Pharmacy ServicesMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		During Q1 2009 the company closed 50 retail pharmacy stores, 5 specialty pharmacy stores and 1 mail order pharmacy; no associated workforce reduction figures are disclosed.
2008-12-31acquisition_additioncompleted2008-08-122008-10-20United StatesRetail Pharmacy / Pharmacy Servicesbusiness_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Acquired Longs Drug Stores Corporation for approximately $2.6 billion, including 529 retail drug stores, RxAmerica LLC and related assets; headcount added through the acquisition is not quantified. Purchase consideration is not a workforce-related charge.
2008-12-31plant_closurecompleted2008-12-31United StatesRetail PharmacyMD&A
f5-10k / MiMo-V2.6-Flash-fp8-HTML		39 retail stores closed during fiscal 2008 (129 retail and 3 specialty stores were relocated). Employees affected by the closures are not disclosed; closed-store lease liability of $600.1 million at year-end relates to lease obligations, not severance.
2008-12-31acquisition_additioncompleted2008-10-202008-10-20United StatesRetail Pharmacy / Pharmacy ServicesItem 1: Business
f5-10k / Qwen3.6-27B-Q8_0		Acquired Longs Drug Stores Corporation (529 retail drug stores) and RxAmerica LLC. Specific headcount added not disclosed.
2008-09-27restructuringin_progress3402007-03-222009-12-31United StatesPharmacy Services (Caremark)USD 55 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Severance, benefits and outplacement for ~340 Caremark employees terminated in connection with the March 2007 merger; $48.9M of the $54.9M liability settled with cash payments as of 2008-09-27, remainder payable through 2009.
2008-09-27acquisition_additioncompleted2008-08-122008-10-30United States (CA, HI, NV, AZ)Retail Pharmacy / Pharmacy Servicessubsequent_events
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Longs acquisition completed 2008-10-30 (subsequent event); added 521 retail drugstores and Rx America subsidiary. Employee headcount added not disclosed.
2008-06-28restructuringcompleted3402007-03-222009-12-31Pharmacy ServicesUSD 54 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Merger-related severance, benefits and outplacement for approximately 340 Caremark employees; substantially all terminated as of 2008-06-28. $48.9M of the liability settled with cash by quarter-end; remaining cash payments run through 2009.
2008-06-28plant_closurecompletedUnited StatesRetail PharmacyMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		During the 26 weeks ended 2008-06-28 the company closed 27 retail pharmacy stores, 2 mail order pharmacies and 1 specialty mail order pharmacy; no associated employee counts or charges disclosed. Same period: 90 new stores opened and 92 retail stores relocated.
2008-03-29restructuringcompleted3402007-03-222009-12-31United StatesPharmacy Services (Caremark)USD 54 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Severance, benefits and outplacement for Caremark employees; substantially all terminated as of 2008-03-29, with $48.1 million of the liability settled in cash and the remainder payable through 2009.
2008-03-29plant_closurecompletedUnited StatesRetail PharmacyMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		19 retail pharmacy stores closed during the thirteen weeks ended March 29, 2008; associated headcount not disclosed.
2008-03-29plant_closurecompletedUnited StatesPharmacy ServicesMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		2 mail order pharmacies and 1 specialty mail order pharmacy closed during the quarter; associated headcount not disclosed.
2007-12-29acquisition_additioncompleted2006-11-012007-03-22United StatesPharmacy Servicesbusiness_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Merger of Caremark Rx, Inc. closed March 22, 2007; Caremark results consolidated from that date. Caremark headcount added through the merger is not quantified in the filing.
2007-12-29restructuringin_progress2402007-03-222008-12-31United StatesPharmacy Services (Caremark)USD 50 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Accrued for severance, benefits and outplacement for approximately 240 Caremark employees terminated or to be terminated as part of merger integration; $48.1 million of the liability settled with cash payments as of fiscal year-end, remainder payable through 2008. Filer notes the amount and headcount may increase as exit plans are finalized.
2007-12-29plant_closurecompleted2007-12-29United StatesRetail PharmacyItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		44 retail stores closed during fiscal 2007 (per store development table: 6,205 beginning stores, 140 new/acquired, 44 closed, 6,301 ending). Associated workforce reduction not quantified; total closed-store lease liability of $441.2 million is a cumulative balance, not a fiscal 2007 charge.
2007-12-29restructuringcompleted2402007-03-222008-12-31United StatesCaremark (Pharmacy Services)USD 50 (millions)business_combinations_footnote
f5-10k / Qwen3.6-27B-Q8_0		Estimated severance, benefits and outplacement costs for approx 240 Caremark employees terminated or to be terminated. $48.1 million settled in cash by Dec 29, 2007; remaining liability requires future payments through 2008.
2007-12-29plant_closurein_progress2006-06-022033-12-31United StatesRetail PharmacyUSD 50 (millions)business_combinations_footnote
f5-10k / Qwen3.6-27B-Q8_0		Liability for non-cancelable lease obligations of 94 acquired stores not intended to be operated. 81 locations closed by Dec 29, 2007. $3.6 million settled; $47.5 million remaining liability.
2007-09-29acquisition_additioncompleted2007-03-222007-03-22United StatesPharmacy Servicesbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Caremark Rx, Inc. merged into a CVS subsidiary effective 2007-03-22; Caremark results included since that date. Headcount added through the merger is not quantified in this filing.
2007-09-29restructuringin_progress2452007-03-222008-12-31United StatesPharmacy ServicesUSD 39 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Accrued severance, benefits and outplacement costs for Caremark employees terminated or to be terminated post-merger; $4.4 million of the liability settled with cash payments as of 2007-09-29, with the remainder payable through 2008. Filer states the accrual and affected-employee count will continue to increase as exit plans are finalized.
2007-09-29plant_closurein_progress2006-06-02United StatesRetail PharmacyUSD 52 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Of 94 acquired Albertson's stores the company does not intend to operate, 80 locations had been closed as of 2007-09-29; remaining $52.3 million lease liability (including $2.6 million interest accretion) payable through 2033. Employees affected by the closures are not disclosed.
2007-09-29restructuringin_progress2452007-03-222008-12-31Caremark Merger IntegrationUSD 39 (millions)business_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0		Accrued expenses include $38.6 million for estimated severance, benefits and outplacement costs for approximately 245 Caremark employees that have been or will be terminated. Remaining liability requires future cash payments through 2008.
2007-09-29plant_closurein_progress2006-06-022033-12-31Standalone Drug BusinessUSD 52 (millions)business_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0		Liability for non-cancelable lease obligations of 94 acquired stores not intended to be operated. 80 locations closed as of Sept 29, 2007. Remaining liability includes interest accretion.
2007-06-30restructuringin_progress2092007-03-222008-12-31United StatesCaremark (Pharmacy Services)USD 35 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Accrued severance, benefits and outplacement costs for Caremark employees terminated or to be terminated as part of merger integration; $0.7 million settled in cash as of June 30, 2007, remainder payable through 2008. Filer notes the count and accrual will increase as exit plans are finalized.
2007-06-30plant_closurein_progress2006-06-02United StatesRetail Pharmacy SegmentUSD 55 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		77 of 94 acquired Albertsons stores the company does not intend to operate had been closed as of June 30, 2007; remaining $55.2 million lease liability (incl. $2.1 million accretion) payable through 2033. No employee count associated with the closures is disclosed.
2007-06-30restructuringin_progress2092007-03-222008-12-31Caremark (Pharmacy Services)USD 35 (millions)business_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0		Estimated severance, benefits and outplacement costs for approximately 209 Caremark employees terminated or to be terminated as part of the Caremark Merger integration. Liability expected to be settled through 2008.
2007-03-31acquisition_additioncompleted2006-11-012007-03-22United StatesPharmacy Benefit Management (PBM)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Merger closed 2007-03-22; Caremark headcount added is not quantified in this filing. Related change-in-control payments of $42.9M pre-tax and accelerated stock option expense of $80.3M pre-tax disclosed but not tied to a headcount figure.
2007-03-31restructuringin_progress9702006-06-022008-12-31United StatesRetail Pharmacy (Standalone Drug Business)USD 6 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Severance, benefits and outplacement liability for 970 employees recorded in fiscal 2006; $1.4M settled with cash payments as of 2007-03-31, $4.8M remaining payable through 2008.
2006-12-30acquisition_additioncompleted2006-06-022006-06-02United StatesRetail Pharmacybusiness_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Acquired roughly 700 standalone drugstores and a distribution center from Albertson's for $4.0 billion; acquired headcount not disclosed.
2006-12-30restructuringin_progress9702006-06-022008-12-31United StatesRetail PharmacyUSD 6 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Approximately 970 acquired employees terminated or scheduled for termination; $1.1M settled by year-end, $5.1M remaining payable through 2008.
2006-12-30plant_closurein_progressUnited StatesRetail PharmacyItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		117 stores closed during fiscal 2006, including 73 acquired Standalone Drug Business stores; associated headcount not disclosed. The acquisition footnote separately records lease liabilities for 76 acquired stores intended to close (74 closed at year-end, $63.6M remaining obligation) — overlapping population, not counted again here.
2006-12-30restructuringcompleted9702006-06-022008-12-31United StatesRetail PharmacyUSD 6 (millions)business_combinations_footnote
f5-10k / Qwen3.6-27B-Q8_0		Estimated severance, benefits and outplacement costs for approximately 970 employees of the Standalone Drug Business acquired from Albertsons. Liability settled through 2008.
2006-12-30plant_closurecompleted2006-06-022033-12-31United StatesRetail PharmacyUSD 64 (millions)business_combinations_footnote
f5-10k / Qwen3.6-27B-Q8_0		Estimated costs associated with non-cancelable lease obligations of 76 acquired stores intended to be closed. 74 locations closed by year-end.
2006-12-30restructuringcompleted1,0902004-07-312009-12-31United StatesRetail PharmacyUSD 11 (millions)business_combinations_footnote
f5-10k / Qwen3.6-27B-Q8_0		Estimated severance, benefits and outplacement costs for 1,090 Eckerd employees from 2004 acquisition. Fully settled by year-end 2006.
2006-12-30plant_closurecompleted2004-07-312030-12-31United StatesRetail PharmacyUSD 350 (millions)business_combinations_footnote
f5-10k / Qwen3.6-27B-Q8_0		Estimated costs associated with non-cancelable lease obligations of 296 Eckerd locations not intended to be operated. 294 closed by year-end 2006.
2006-09-30acquisition_additioncompleted2006-06-02United States (southern California, Midwest, Southwest)Retail Pharmacybusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Acquisition of approximately 700 standalone drugstores and a distribution center for $4.0 billion; employee headcount added not disclosed. Results included in consolidated statements from 2006-06-02.
2006-09-30layoffin_progress9702006-06-02United StatesRetail Pharmacy (Standalone Drug Business)USD 6 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Severance accrual for approximately 970 employees of the acquired Standalone Drug Business expected to be terminated; $0.9 million settled with cash payments as of 2006-09-30.
2006-09-30plant_closurein_progress2006-06-02United StatesRetail Pharmacy (Standalone Drug Business)USD 63 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		75 acquired stores intended for closure; 70 closed as of 2006-09-30. Remaining liability of $62.9 million (includes $0.3 million interest accretion) for lease exit costs, payable through 2033. Associated headcount not disclosed.
2006-09-30layoffin_progress1,0902004-07-31United StatesRetail Pharmacy and Health Services (Eckerd)USD 11 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Severance, benefits and outplacement costs for 1,090 Eckerd employees that have been or will be terminated; $8.1 million settled as of 2006-09-30, $1.6 million remaining payable through 2007.
2006-09-30plant_closurein_progress2004-07-31United StatesRetail Pharmacy (Eckerd locations)USD 223 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Original liability of $349.8 million for 299 Eckerd locations not intended for operation; 290 closed and $133.5 million settled as of 2006-09-30. Remaining $223.0 million (includes $15.6 million interest accretion) payable through 2030. Associated headcount not disclosed.
2006-07-01acquisition_additioncompleted2006-06-02United States (approximately half in southern California; remainder in Midwest and Southwest)Retail PharmacyUSD 4,000 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Acquisition of approximately 700 standalone drugstores and a distribution center for $4.0 billion; employee headcount added not disclosed
2006-07-01reduction_in_forceannounced9702006-06-02United StatesRetail Pharmacy (Standalone Drug Business)USD 6 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Severance accrual for approximately 970 employees of the acquired Standalone Drug Business expected to be terminated; none settled with cash payments as of July 1, 2006
2006-07-01plant_closureannounced2006-06-02United StatesRetail Pharmacy (Standalone Drug Business)USD 58 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		75 acquired stores intended for closure; $57.6M in other long-term liabilities plus $6.6M in accrued expenses; no cash payments settled as of July 1, 2006; associated employee reductions not quantified
2006-07-01plant_closurein_progress2004-07-31United StatesRetail Pharmacy (Eckerd locations)USD 234 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Liability for non-cancelable leases of 299 Eckerd locations; 285 closed and $123.2M settled as of July 1, 2006; remaining $234.1M payable through 2030; associated employee reductions not quantified
2006-07-01reduction_in_forcein_progress1,0902004-07-312007-12-31United StatesRetail Pharmacy and Health Services (Eckerd)USD 3 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Original $10.5M severance accrual for 1,090 Eckerd employees; $8.0M settled as of July 1, 2006; remaining $2.5M payable through 2007
2006-04-01acquisition_additionannounced2006-01-222006-06-30United States (southern California, Midwest, Southwest)Retail Pharmacyother
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Definitive agreement to acquire approximately 700 standalone Sav-on and Osco drugstores plus a La Habra, CA distribution center from Albertson's for $3.93 billion cash, expected to close early June 2006. No employee headcount associated with the transaction is disclosed in this filing.
2006-04-01plant_closurecompletedUnited StatesRetail PharmacyMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Company closed 23 stores during the quarter (also opened 35 and relocated 40). No associated workforce reduction count or charge is disclosed.
2005-12-31plant_closurecompleted2005-12-31United StatesRetail PharmacyItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		70 retail stores closed during fiscal 2005; associated workforce reduction not quantified in the filing.
2005-12-31plant_closurein_progress2004-07-31United StatesRetail PharmacyUSD 350 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Cumulative through fiscal year-end: 275 of 302 acquired Eckerd locations not intended for operation had been closed by 2005-12-31; $264.4 million of the $349.8 million lease liability remained unsettled. Employees affected not disclosed; closures originated in the July 2004 acquisition.
2005-12-31acquisition_additionannounced2006-01-222006-06-30United States (southern California, Midwest, Southwest)Retail Pharmacysubsequent_events
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Post-year-end agreement to acquire ~700 stores plus a distribution center for $2.93 billion cash, plus $1.0 billion for owned real estate; closing expected mid-2006 and conditioned on the Albertson's/Supervalu merger. Headcount to be added not disclosed.
2005-12-31acquisition_additioncompleted2004-07-312004-07-31United StatesRetail Pharmacy and PBMUSD 2,100 (millions)Item 1. Business - Recent Development / Note 2
f5-10k / Qwen3.6-27B-Q8_0		Acquired Eckerd Corporation assets including more than 1,200 retail drugstores and PBM businesses on July 31, 2004. Final purchase price was $2.1 billion. Specific headcount added not disclosed.
2005-12-31plant_closurecompleted2005-12-312005-12-31United StatesRetail PharmacyItem 1. Business - Store Development
f5-10k / Qwen3.6-27B-Q8_0		Closed 70 stores during fiscal 2005. Employee count affected not disclosed.
2005-12-31acquisition_additionannounced2006-01-222006-06-30United StatesRetail PharmacyUSD 2,930 (millions)subsequent_events
f5-10k / Qwen3.6-27B-Q8_0		Agreement to acquire approximately 700 standalone Sav-on and Osco drugstores from Albertson's for $2.93 billion. Closing expected mid-2006. Employee count not disclosed.
2005-07-02plant_closurecompletedUnited StatesRetail PharmacyMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Closed 39 stores during the 26 weeks ended July 2, 2005; no associated headcount or charge disclosed. Same period: 103 new stores opened, 75 relocated.
2005-04-02acquisition_additioncompleted2004-07-31United StatesRetail Pharmacy; Pharmacy Benefit Managementbusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Acquisition of Eckerd Corporation assets from J.C. Penney (1,268 retail drugstores plus mail order/PBM businesses) closed 2004-07-31; no employee headcount added or affected is disclosed in this filing.
2005-01-01acquisition_additioncompleted2004-07-312004-07-31United StatesRetail Pharmacy; Pharmacy Benefit ManagementUSD 2,150 (millions)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Acquired 1,268 Eckerd retail drugstores plus Eckerd Health Services (mail order and PBM) from J.C. Penney. Purchase price $2.15 billion adjusted for working capital. Headcount added not disclosed.
2005-01-01plant_closurecompleted2005-01-01United StatesRetail PharmacyItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		201 stores closed during 2004, including 160 stores of the Acquired Businesses. Associated headcount reduction not disclosed.
2005-01-01acquisition_additioncompleted2004-07-312004-07-31United StatesRetail Pharmacy and PBMItem_1_Business
f5-10k / Qwen3.6-27B-Q8_0		Acquired 1,268 Eckerd retail drugstores and Eckerd Health Services (mail order and PBM). Specific headcount added not disclosed.
2004-10-02acquisition_additioncompleted2004-07-31United StatesRetail Pharmacy; PBMUSD 2,150 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Acquisition of 1,268 Eckerd retail drugstores and Eckerd Health Services from J.C. Penney; purchase price $2.15 billion subject to working capital adjustment. Employee headcount added not disclosed.
2004-07-03acquisition_additioncompleted2004-07-31United States (primarily Florida and Texas; also Louisiana, Oklahoma, Mississippi, Arizona, Missouri, Kansas, Alabama)Retail Pharmacy and PBM (Eckerd drugstores, Eckerd Health Services mail order/PBM, three distribution centers)subsequent_events
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Acquisition of Eckerd Operations from J.C. Penney closed July 31, 2004 (after quarter end, before filing); initial purchase price $2.15 billion. No employee headcount transferred was disclosed; approximately 1,260 drugstores and three distribution centers acquired. Results not included in periods presented.
2004-04-03acquisition_additionannounced2004-04-04United States (mainly southern U.S., including Texas and Florida)Retail Pharmacy; PBM (mail order, specialty pharmacy, pharmacy benefit management)USD 2,150 (millions)MD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Asset Purchase Agreement with J.C. Penney / Eckerd to acquire approximately 1,260 drugstores plus mail order, specialty pharmacy and PBM business for $2.15 billion, subject to post-closing working capital adjustment and HSR clearance. No employee headcount for the acquired business is disclosed; purchase price recorded as acquisition consideration, not a workforce charge.
2004-01-03plant_closurecompleted2004-01-03United StatesRetail PharmacyItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		58 retail stores closed during fiscal 2003; no associated employee count or charge disclosed
2004-01-03restructuringcompleted1,5002001-10-012002-04-30United StatesCorporate Headquarters, Mail Facility, Distribution Center, StoresUSD 20 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0		Part of 2001 strategic restructuring. 1,500 managerial, administrative, and store employees terminated. Severance charge of $19.5 million. All terminations completed as of April 30, 2002.
2003-09-27plant_closurecompletedUnited StatesRetail PharmacyMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Filer reports 44 stores closed during the 39 weeks ended 2003-09-27 (alongside 94 new stores opened and 66 relocated). No associated employee count or severance charge disclosed.
2003-09-27restructuringin_progress2024-12-31United StatesRetail PharmacyUSD 175 (millions)MD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Ongoing 2001 strategic restructuring: $16.5M paid in the 39 weeks ended 2003-09-27 ($5.2M in Q3); remaining estimated payments of $174.7M are noncancelable lease obligations extending through 2024. No employee counts disclosed in this filing.
2003-06-28plant_closurecompletedUnited StatesRetail PharmacyMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		37 stores closed during the 26 weeks ended June 28, 2003; no associated employee count disclosed.
2002-12-28restructuringcompleted1,50020012002-04-30United StatesCorporate headquarters, distribution, mail order and retail storesUSD 353 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		2001 strategic restructuring approved in Q4 2001; program comprised closure of 229 stores (all closed by 2002-03-31), the Henderson NC distribution center (closed April 2002), the Columbus OH mail facility (closed March 2002), two satellite offices (closed December 2001), and termination of approximately 1,500 managerial, administrative and store employees (all terminated by 2002-04-30). The $352.5 million pre-tax charge ($230.5 million after-tax) was recorded in Q4 2001; remaining future cash payments of $192.1 million for noncancelable lease obligations extend through 2024. Employee terminations and most closures occurred within fiscal 2002.
2002-12-28plant_closurecompleted2002-12-28United StatesRetail PharmacyItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		278 stores closed during fiscal 2002, of which 224 resulted from the 2001 strategic restructuring captured above; the filer does not separately quantify headcount for the closures or break out a standalone count for non-restructuring closures. 174 new stores were opened and 92 stores relocated during 2002.
2002-12-28restructuringcompleted1,50020012002-04-30United StatesCorporate, Distribution, Mail Order, Retail StoresUSD 20 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0		Approximately 1,500 managerial, administrative and store employees terminated as part of 2001 strategic restructuring. All terminated by April 30, 2002. Severance charge of $19.5 million.
2002-09-28restructuringcompleted1,50020012002-04-30United States (Rhode Island corporate headquarters; Columbus, OH; Henderson, NC; closed store locations)Managerial, administrative and store employees (Retail Pharmacy and PBM)USD 20 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Approximately 1,500 employees terminated by April 30, 2002 under the Action Plan approved in Q4 2001. Severance and benefits component of the charge was $19.5M pre-tax; total Action Plan restructuring and asset impairment charge was $352.5M pre-tax ($230.5M after-tax), including $227.4M noncancelable lease obligations and $105.6M asset write-offs. Announcement date known only as Q4 2001.
2002-09-28plant_closurecompleted20012002-03-31United States (27 states and District of Columbia)Retail Pharmacy and PBM (CVS/pharmacy and CVS ProCare stores)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		229 leased store locations closed by March 31, 2002 as part of the Action Plan; premises to be returned to landlords or leases terminated early. Noncancelable lease obligations of $197.6M remained at quarter-end. Announcement date known only as Q4 2001.
2002-09-28plant_closurecompleted20012002-04-30Henderson, North CarolinaDistribution center operationsrestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Owned distribution center closed in April 2002 and sold in May 2002; operations transferred to remaining distribution centers. Announcement date known only as Q4 2001.
2002-09-28plant_closurecompleted20012002-03-31Columbus, OhioPBM mail order pharmacy operationsrestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Leased mail order facility closed in March 2002; operations transferred to the Pittsburgh, Pennsylvania mail order facility. Announcement date known only as Q4 2001.
2002-09-28plant_closurecompleted20012001-12-31United StatesCorporate (two satellite office facilities)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Two leased satellite offices closed in December 2001 with operations consolidated into Woonsocket, Rhode Island headquarters; closure occurred just prior to the fiscal 2002 reporting period but is disclosed in this filing's Action Plan roll-forward. Announcement date known only as Q4 2001.
2002-09-28othercompleted2002-07-01United States (Federal District Court of Alabama)Pharmacists (current and former)other
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Settlement reached during Q3 2002 in Hill v. CVS Rx Services, Inc., a collective action alleging Fair Labor Standards Act violations by certain current and former CVS pharmacists; a related litigation accrual was recorded, contributing to a $7.0M pre-tax net nonrecurring litigation gain for the quarter. Number of affected employees not disclosed; announcement date is the quarter of settlement (exact date not stated).
2002-09-28restructuringcompleted1,5002001-10-012002-04-30United StatesCorporate, Distribution, Mail Order, Retail StoresUSD 20 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Approximately 1,500 managerial, administrative and store employees terminated as part of 2001 Action Plan. Terminations completed by April 30, 2002. Severance liability balance was $4.7 million as of Sept 28, 2002.
2002-09-28plant_closurecompleted2001-10-012002-03-31United StatesRetail Pharmacyrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		229 CVS/pharmacy and CVS ProCare store locations closed by March 31, 2002. Employee count for closures not separately disclosed from total restructuring terminations.
2002-09-28plant_closurecompleted2001-10-012002-04-30Henderson, North CarolinaDistributionrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Henderson distribution center closed in April 2002 and sold in May 2002. Operations transferred to remaining centers.
2002-09-28plant_closurecompleted2001-10-012002-03-31Columbus, OhioPharmacy Benefit Managementrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Columbus mail order facility closed in March 2002. Operations transferred to Pittsburgh facility.
2002-09-28plant_closurecompleted2001-10-012001-12-31United StatesCorporaterestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Two satellite office facilities closed in December 2001. Operations consolidated into Woonsocket headquarters.
2002-06-29restructuringcompleted1,50020012002-04-30United StatesCorporate headquarters, distribution, mail order, retail storesUSD 353 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Approved Q4 2001; charge recorded in Q4 2001. Components: 229 stores closed by Mar 2002, Henderson NC DC closed Apr 2002, Columbus OH mail facility closed Mar 2002, two satellite offices closed Dec 2001, ~1,500 employees terminated by Apr 30 2002. Reserve balance $214.3M remaining at quarter-end, primarily noncancelable lease obligations through 2024.
2002-06-29plant_closurecompleted20012002-03-31United StatesRetail Pharmacyrestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		229 CVS/pharmacy and CVS ProCare store locations closed by March 2002 as part of the Action Plan; all were leased facilities. Workforce impact included within the ~1,500 total terminations.
2002-06-29plant_closurecompleted20012002-05-31Henderson, North Carolina, United StatesDistributionrestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Henderson NC distribution center closed April 2002 and property sold May 2002; owned facility. Workforce impact included within the ~1,500 total terminations.
2002-06-29plant_closurecompleted20012002-03-31Columbus, Ohio, United StatesPBM — Mail Orderrestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Columbus OH mail order facility closed March 2002; operations transferred to Pittsburgh PA facility. Leased facility. Workforce impact included within the ~1,500 total terminations.
2002-06-29restructuringcompleted1,5002001-10-012002-04-30United StatesManagerial, administrative and store employeesUSD 20 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Approximately 1,500 employees terminated as part of Action Plan approved in Q4 2001. Terminations completed by April 30, 2002. Severance liability balance was $5.3 million as of June 29, 2002.
2002-06-29plant_closurecompleted2001-10-012002-03-31United StatesRetail Pharmacyrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		229 CVS/pharmacy and CVS ProCare store locations closed by March 31, 2002. Employee count for closures not separately disclosed.
2002-06-29plant_closurecompleted2001-10-012002-04-30Henderson, North CarolinaDistributionrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Henderson distribution center closed in April 2002 and sold in May 2002. Employee count not separately disclosed.
2002-06-29plant_closurecompleted2001-10-012002-03-31Columbus, OhioPharmacy Benefit Managementrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Columbus mail order facility closed in March 2002. Operations transferred to Pittsburgh. Employee count not separately disclosed.
2002-06-29plant_closurecompleted2001-10-012001-12-31United StatesCorporaterestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Two satellite office facilities closed in December 2001. Operations consolidated to Woonsocket headquarters. Employee count not separately disclosed.
2002-03-30restructuringcompleted1,50020012002-04-30United StatesCorporate headquarters, mail order facility, distribution center, and retail storesUSD 20 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Approximately 1,500 managerial, administrative and store employees terminated as part of Action Plan approved in Q4 2001; all terminated as of April 30, 2002. Severance portion of $352.5M total pre-tax restructuring charge.
2002-03-30plant_closurecompleted20012002-03-31United StatesRetail Pharmacy and PBM (CVS ProCare)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		229 CVS/pharmacy and CVS ProCare store locations closed by March 2002; all leased facilities. Employee count not separately disclosed for store closures.
2002-03-30plant_closurecompleted20012002-05-31Henderson, North Carolina, United StatesDistributionrestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Owned distribution center closed April 2002 (subsequent to quarter end); operations transferred to remaining DCs; property under contract to be sold.
2002-03-30plant_closurecompleted20012002-04-30Columbus, Ohio, United StatesPBM — Mail Order Pharmacyrestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Leased mail order facility closed March 2002; operations transferred to Pittsburgh, Pennsylvania facility.
2002-03-30plant_closurecompleted20012001-12-31United StatesCorporaterestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Two leased satellite office facilities closed December 2001; operations consolidated into Woonsocket, Rhode Island headquarters.
2002-03-30restructuringcompleted1,5002001-10-012002-04-30United StatesManagerial, administrative and store employeesUSD 20 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Termination of approximately 1,500 employees in Woonsocket HQ, Columbus Mail Facility, Henderson D.C., and Stores. Completed by April 30, 2002. Severance portion of $352.5M total pre-tax charge.
2002-03-30plant_closurecompleted2001-10-012002-03-31United StatesRetail Pharmacyrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Closure of 229 CVS/pharmacy and CVS ProCare store locations. All closed by March 31, 2002.
2002-03-30plant_closurecompleted2001-10-012002-04-30Henderson, North CarolinaDistributionrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Closure of Henderson distribution center. Closed in April 2002.
2002-03-30plant_closurecompleted2001-10-012002-04-30Columbus, OhioPharmacy Benefit Managementrestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Closure of Columbus mail order facility. Closed in March 2002.
2002-03-30plant_closurecompleted2001-10-012001-12-31United StatesCorporaterestructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Closure of two satellite office facilities. Closed in December 2001.
2001-12-29restructuringin_progress1,5002002-05-31United States (corporate headquarters in Rhode Island; Columbus, Ohio; Henderson, North Carolina; closing store locations across multiple states)Corporate headquarters, mail order facility, distribution center, retail and specialty storesUSD 353 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Action Plan approved during Q4 2001 (exact announcement date not disclosed). Program comprises closing 229 CVS/pharmacy and CVS ProCare stores, the Henderson NC distribution center, the Columbus OH mail order facility, two satellite offices, and related staff reductions. Severance component of the charge was $19.5 million covering approximately 1,500 managerial, administrative and store employees; total charge $352.5 million pre-tax ($346.8M operating expenses plus $5.7M inventory markdown). As of March 2002, all 229 stores closed and about 90% of affected employees terminated; remaining terminations (primarily at the distribution center) expected in Q2 2002. Remaining future cash payments of $244.8 million, primarily noncancelable lease obligations through 2024.
2001-12-29restructuringin_progress1,5002001-10-012002-06-30United StatesCorporate, Distribution, Mail Order, Retail StoresUSD 20 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0		Action Plan approved in Q4 2001. Includes severance for approx. 1,500 managerial, administrative, and store employees. As of March 2002, approx. 90% terminated; remaining primarily in Distribution Center to be terminated in Q2 2002.
2001-09-29restructuringannounced2001-10-302001-12-31United StatesRetail Pharmacy, Distribution, Specialty Pharmacy (ProCare)USD 350 (millions)MD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Action Plan announced post-quarter: close ~200 stores, one of ten distribution facilities, one of ProCare's two mail order facilities, plus staff reductions; pre-tax charge ~$350M ($0.56 per diluted share) expected in Q4 2001. No employee count disclosed; Action Plan not yet finalized.
2001-09-29plant_closureannounced2001-10-302001-12-31United StatesRetail Pharmacy (store consolidation)MD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Sub-component of the consolidated Action Plan restructuring: approximately 200 stores to be closed. Charge not allocated to this component.
2001-09-29plant_closureannounced2001-10-302001-12-31United StatesDistributionMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Sub-component of the consolidated Action Plan: closure of one of ten distribution facilities. Charge not allocated to this component.
2001-09-29plant_closureannounced2001-10-302001-12-31United StatesSpecialty Pharmacy (ProCare mail order)MD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Sub-component of the consolidated Action Plan: closure of one of ProCare's two mail order facilities. Charge not allocated to this component.
2001-09-29restructuringannounced2001-10-302001-12-31United StatesRetail Pharmacy, Distribution, Specialty PharmacyUSD 350 (millions)subsequent_events
f5-10q / Qwen3.6-27B-Q8_0		Announced Action Plan includes closing approx. 200 stores, one distribution facility, one mail order facility, and staff reductions. Pre-tax charge of approx. $350 million expected in Q4 2001.
2000-12-30acquisition_additioncompleted2000-09-182000-09-18United StatesSpecialty PharmacyUSD 124 (millions)MD&A
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Acquisition of certain assets of Stadtlander Pharmacy for $124 million cash plus assumed liabilities; headcount added not disclosed.
2000-12-30plant_closurecompleted2000-12-30United StatesRetail PharmacyMD&A
f5-10k / MiMo-V2.6-Flash-fp8-HTML		123 stores closed during fiscal 2000; associated headcount reduction not disclosed.
2000-12-30restructuringin_progress1998-03-312020-12-31United StatesCorporate / Retail PharmacyUSD 47 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Remaining CVS/Arbor merger restructuring liability of $46.7M at fiscal year-end; noncancelable lease obligations extend through 2020. Original $147.3M charge recorded in 1998; current-year utilization was $4.3M cash.
2000-12-30restructuringcompleted2361998-03-311998-12-31Troy, MichiganCorporate HeadquartersUSD 27 (millions)business_combinations_footnote
f5-10k / Qwen3.6-27B-Q8_0		Termination of 236 employees at Arbor's Troy, Michigan corporate headquarters. Charge includes severance, benefits, and outplacement costs. Completed by Dec 31, 1998.
2000-12-30plant_closurecompleted1998-03-312000-12-30VariousRetail StoresUSD 40 (millions)business_combinations_footnote
f5-10k / Qwen3.6-27B-Q8_0		Closure of 55 Arbor store locations. Charge represents noncancelable lease obligations. All locations closed or in process of closing as of Dec 30, 2000.
2000-09-30acquisition_additioncompleted2000-09-182000-09-18Pittsburgh, Pennsylvania, United StatesRetail PharmacyUSD 124 (millions)MD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Acquisition of certain assets of Stadtlander Pharmacy (Bergen Brunswig subsidiary) for $124M cash plus assumed liabilities. No employee headcount disclosed.
2000-09-30restructuringin_progress1998-06-302020-12-31United StatesCorporate / Retail (CVS/Arbor merger)USD 147 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Ongoing CVS/Arbor merger restructuring from 1998. Remaining liability $47.4M at 9/30/00. Includes Troy MI HQ closure, store closures, severance. No employee count disclosed. Noncancelable lease obligations extend through 2020.
2000-09-30restructuringin_progress1998-04-012020-12-31United StatesCorporate Headquarters and Retail StoresUSD 47 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Remaining liability balance as of Sept 30, 2000 for merger-related costs and restructuring activities initiated in Q2 1998. Includes $9.4M employee severance/benefits and $34.6M noncancelable lease obligations.
2000-09-30acquisition_additioncompleted2000-09-182000-09-18Pittsburgh, PARetail PharmacyUSD 124 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0		Acquisition of certain assets of Stadtlander Pharmacy. Headcount added not explicitly disclosed.
2000-07-01restructuringin_progress1998-04-012020-12-31United StatesCorporate Headquarters / RetailUSD 2 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Cash utilization of $1.5 million during the quarter ended July 1, 2000 for the CVS/Arbor merger restructuring. Remaining liability of $49.5 million includes $9.7 million for employee severance and $36.4 million for noncancelable lease obligations.
2000-07-01plant_closurecompleted2000-01-022000-07-01United StatesRetail PharmacyMD&A
f5-10q / Qwen3.6-27B-Q8_0		Closed 78 stores during the first six months of 2000. Employee count impact not disclosed.
2000-04-01restructuringin_progress1998-04-012020-12-31United StatesCorporate Headquarters and Retail StoresUSD 0 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Utilization of $0.4 million in cash during Q1 2000 for ongoing restructuring activities related to the 1998 CVS/Arbor merger, including employee severance and lease obligations. Total remaining liability is $50.6 million.
2000-04-01plant_closurecompleted2000-01-022000-04-01United StatesRetail PharmacyMD&A
f5-10q / Qwen3.6-27B-Q8_0		Closed 49 stores during the first quarter of 2000 as part of ongoing store optimization and relocation program.
2000-01-01plant_closurecompleted2000-01-01United StatesRetail PharmacyMD&A
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Normal-course store closures during fiscal 1999; no employee count or associated charge disclosed. MD&A capital expenditures section also notes 146 new stores opened and 299 relocations during 1999.
2000-01-01restructuringin_progress1998-03-31United StatesRetail Pharmacy — CVS/Arbor merger integrationUSD 147 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Multi-year program; original $147.3M charge recorded Q2 1998 (prior fiscal year). During fiscal 1999, $5.7M cash utilized against remaining $56.7M reserve (balance $51.0M at year-end). Program covers closure of 55 Arbor store locations and Troy, MI headquarters. 41 of 55 stores closed or in process as of filing date (cumulative, not fiscal-1999-specific). HQ employee terminations (236 employees) completed by end of 1998. Remaining employee severance reserve $10.3M at year-end.
2000-01-01restructuringin_progress1997-05-29United StatesRetail Pharmacy — CVS/Revco merger integrationUSD 337 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Multi-year program; original $337.1M charge recorded Q2 1997 (prior fiscal year). All 223 Revco store closures and HQ employee terminations (1,195 employees) completed by end of 1998. During fiscal 1999, $13.3M cash utilized against remaining $61.5M reserve (balance $48.2M at year-end), primarily lease obligations ($9.9M) and employee severance/benefits ($3.4M). Fiscal 1999 activity is reserve settlement rather than new workforce reductions.
2000-01-01restructuringin_progress2361998-03-312000-12-31MichiganCorporate HeadquartersUSD 27 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0		Severance and benefits for 236 employees at Arbor's Troy, MI headquarters. Employee severance extends through 2000.
2000-01-01restructuringin_progress1,1951997-05-291999-12-31OhioCorporate HeadquartersUSD 90 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0		Severance and benefits for 1,195 employees at Revco's Twinsburg, OH headquarters. Employee severance extended through 1999.
2000-01-01restructuringin_progress1997-06-012000-12-31United StatesCorporateUSD 35 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0		Employee severance from strategic restructuring program (sales of Marshalls, Kay-Bee, etc.). Severance extends through 2000. Specific headcount not disclosed in footnote.
1999-09-25restructuringin_progress1998-01-012020-12-31United StatesCorporate Headquarters and StoresUSD 158 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Charge recorded in Q1 1998 for merger-related costs and restructuring, including closing Arbor's Troy, MI headquarters and certain stores. Remaining liability at 9/25/99 was $53.4 million.
1999-09-25restructuringin_progress1997-01-012017-12-31United StatesCorporate Headquarters and StoresUSD 412 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Charge recorded in Q2 1997 for merger-related costs and restructuring, including closing Revco's Twinsburg, OH headquarters and certain stores. Remaining liability at 9/25/99 was $50.9 million.
1999-09-25restructuringin_progress1997-01-012012-12-31United StatesBig B, Inc.USD 31 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Charge recorded in Q1 1997 for restructuring of Big B, Inc. Remaining cash outlays primarily include noncancelable lease obligations.
1999-09-25restructuringin_progress1995-10-012016-12-31United StatesCorporate and Discontinued OperationsUSD 1,142 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Comprehensive program announced Oct 1995 including sales of Marshalls, Kay-Bee Toys, Wilsons, This End Up, Bob's Stores; spin-off of Footstar; IPO of Linens 'n Things; and closure of Rye, NY office. Remaining liability at 9/25/99 was $28.7 million.
1999-06-26restructuringin_progress1998-03-312020-12-31United StatesCorporate and StoresUSD 158 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Charge recorded in Q1 1998 for merger-related costs and restructuring including closure of Arbor's Troy, MI headquarters and certain stores. Remaining liability $54.3M as of June 26, 1999.
1999-06-26restructuringin_progress1997-06-302017-12-31United StatesCorporate and StoresUSD 412 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Charge recorded in Q2 1997 for merger-related costs and restructuring including closure of Revco's Twinsburg, OH headquarters and certain stores. Remaining liability $52.6M as of June 26, 1999.
1999-06-26restructuringin_progress1997-03-312012-12-31United StatesBig B, Inc.USD 31 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Charge recorded in Q1 1997 for restructuring of Big B, Inc. Remaining cash outlays primarily include noncancelable lease obligations.
1999-06-26restructuringin_progress1995-10-312016-12-31United StatesCorporate and StoresUSD 1,142 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Comprehensive program announced Oct 1995 including sales of Marshalls, Kay-Bee Toys, Wilsons, This End Up, Bob's Stores; spin-off of Footstar; IPO of Linens 'n Things; closure of Rye, NY office. Remaining liability $80.2M as of June 26, 1999.
1998-12-31acquisition_additioncompleted1998-03-311998-03-31United StatesRetail Drugstoresbusiness_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		CVS/Arbor merger completed 1998-03-31; 37.8M CVS shares exchanged for all Arbor shares; headcount added not separately disclosed
1998-12-31restructuringcompleted2001998-03-311998-12-31United StatesCorporate / RetailUSD 158 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		CVS/Arbor merger-related restructuring; charge recorded Q2 1998; includes severance for ~200 employees, asset write-offs of $41.2M, and noncancelable lease obligations; all severance terminations completed by 1998-12-31
1998-12-31plant_closurecompleted1998-12-31United StatesRetail DrugstoresMD&A
f5-10k / MiMo-V2.6-Flash-fp8-HTML		156 stores closed during 1998; associated employee count not disclosed
1998-12-31restructuringcompleted2001998-03-311998-12-31United StatesCorporate / GeneralUSD 27 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0		Employee severance and benefits associated with the CVS/Arbor Merger. All terminations occurred as of December 31, 1998.
1998-12-31restructuringcompleted1,0001997-05-291998-12-31United StatesCorporate / GeneralUSD 90 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0		Employee severance and benefits associated with the CVS/Revco Merger. All terminations occurred as of December 31, 1998.
1998-12-31acquisition_additioncompleted1998-03-311998-03-31United StatesRetailbusiness_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Merger with Arbor Drugs, Inc.; 37.8 million CVS shares exchanged for all Arbor shares; acquired employee headcount not disclosed
1998-12-31plant_closurecompleted2361998-03-311998-12-31United States — Troy, MichiganCorporate HeadquartersUSD 147 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Closure of Arbor's Troy, MI corporate HQ; 236 employees terminated including 22 senior executives; facility closed December 1998; charge recorded Q2 1998; total CVS/Arbor Charge of $147.3M also covers 55 store closures and other exit costs
1998-12-31plant_closurein_progress1998-03-311999-12-31United StatesRetail — StoresUSD 147 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		55 Arbor store locations planned for closure; 3 closed as of 1998-12-31; employee count per store not disclosed; charge shared with HQ closure record
1998-12-31plant_closurecompleted1,1951997-05-291998-03-31United States — Twinsburg, OhioCorporate HeadquartersUSD 337 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Closure of Revco's Twinsburg, OH corporate HQ completed March 1998; 1,195 employees terminated including 26 senior executives; charge of $337.1M recorded Q2 1997; program execution continued into FY1998
1998-12-31plant_closurein_progress1997-05-291998-12-31United StatesRetail — StoresUSD 337 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		223 Revco store locations planned for closure; 218 closed as of 1998-12-31; employee count per store not disclosed; charge recorded Q2 1997; program execution continued into FY1998
1998-09-26restructuringin_progress2001998-03-31Troy, Michigan, United StatesCorporate / administrative functionsUSD 27 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Consolidation of administrative functions following the Arbor merger; reduction of approximately 200 employees. Total program charge $158.3M (severance $27.1M, exit costs $116.2M, merger transaction costs $15.0M); $42.7M utilized, $115.6M balance at 1998-09-26. Remaining cash outlays expected in 1998 and beyond.
1998-09-26restructuringin_progress1997-05-29United StatesCorporate / administrative functionsUSD 90 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Employee severance component of the $411.7M Revco Restructuring Charge; $57.5M utilized, $32.3M balance at 1998-09-26. No employee count disclosed. Program also includes $286.9M exit costs and $35.0M merger transaction costs; remaining cash outlays expected in 1998 and beyond.
1998-09-26restructuringin_progress2001998-03-31Troy, MichiganAdministrative functionsUSD 158 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Reduction of approximately 200 employees primarily in Arbor's headquarters; includes consolidation and closure of certain facilities.
1998-06-27restructuringin_progress2001998-03-311999-12-31United States — Troy, MichiganAdministrative / Corporate HeadquartersUSD 158 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Consolidation of administrative functions following CVS/Arbor merger; includes $27.1M employee severance, $116.2M exit costs, $15.0M merger transaction costs. $138.6M balance remaining at quarter end; cash outlays primarily in 1998 and 1999. Also includes closure of certain facilities.
1998-06-27plant_closurecompleted1998-06-27United StatesRetail StoresMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		48 stores closed during Q2 1998 (107 year-to-date). Workforce impact not quantified in filing. Store count declined from 4,120 at June 28, 1997 to 4,056 at June 27, 1998, partly due to divestiture of 120 Revco stores under FTC consent decree.
1998-06-27restructuringin_progress2001998-03-31Troy, MichiganAdministrative functionsUSD 27 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Reduction of approximately 200 employees primarily in Arbor's headquarters as part of CVS/Arbor Merger integration.
1998-03-28acquisition_additioncompleted1998-03-311998-03-31United StatesRetail PharmacyUSD 114 (millions)business_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Stock-for-stock merger completed 1998-03-31 (subsequent event). Approximately 18.9 million CVS shares issued; one-time merger-related charges of ~$114.0 million after tax expected in Q2 1998. No employee headcount added disclosed.
1998-03-28plant_closurecompletedUnited StatesRetail StoresMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		59 stores closed during Q1 1998; 63 stores opened (including 36 relocations). No associated workforce reduction figures disclosed.
1998-03-28restructuringcompletedUSD 31 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0		Charge recorded in Q1 1997 for non-capitalizable costs associated with the restructuring of Big B Inc.
1998-03-28acquisition_additioncompleted1998-03-31USD 114 (millions)business_combinations_footnote
f5-10q / Qwen3.6-27B-Q8_0		Merger with Arbor Drugs, Inc. completed March 31, 1998. Expected one-time merger-related charges of approximately $114.0 million (after tax) to be recorded in Q2 1998.
1997-12-31restructuringin_progress1,0001997-05-291998-12-31United StatesCorporate headquarters (Revco Twinsburg, Ohio)USD 412 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Charge of $411.7M recorded in Q2 1997 covering merger transaction costs ($35.0M), employee severance ($89.8M), and exit costs ($286.9M). Approximately 1,000 employees reduced, primarily at Revco's Twinsburg, Ohio headquarters. $216.1M reserve balance remained at 12/31/97; remaining cash outlays expected in 1998 and beyond.
1997-12-31divestiture_reductioncompleted1997-05-291997-12-31United StatesRetail drugstores (Revco)Item_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		120 Revco stores divested primarily in Richmond and Tidewater area of Virginia pursuant to FTC consent decree. No employee count disclosed for divested stores.
1997-12-31restructuringcompleted1997-01-011997-12-31United StatesBig B, Inc. (acquired 1996) — stores, distribution, corporateUSD 31 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Charge recorded in Q1 1997 for non-capitalizable restructuring costs: $5.3M store/distribution/system conversion, $18.7M store closing costs, $7.0M duplicate headquarters/administration. No specific employee count disclosed.
1997-12-31divestiture_reductioncompleted1997-06-041997-06-04United StatesLinens 'n Things (32.5% remaining interest sold)discontinued_operations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Company sold remaining 32.5% ownership interest in Linens 'n Things for ~$147M. No employee count disclosed.
1997-12-31divestiture_reductioncompleted1997-11-251997-11-25United StatesBob's Storesdiscontinued_operations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Sale of Bob's Stores completed for ~$92M. No employee count disclosed.
1997-12-31acquisition_additioncompleted1997-05-291997-05-29United StatesRetail drugstores (Revco D.S., Inc.)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Stock-for-stock merger completed May 29, 1997; 60.3M CVS shares issued. Pooling of interests accounting. No employee headcount addition disclosed for the acquisition.
1997-12-31acquisition_additioncompleted1996-11-161996-12-23United StatesRetail drugstores (Big B, Inc.)business_combinations_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Big B operated approximately 400 drugstores in five southern states. Acquisition completed in 1996; restructuring costs incurred in 1997. No employee headcount addition disclosed.
1997-12-31otherannounced1998-02-081998-03-31United StatesRetail drugstores (Arbor Drugs, Inc.)subsequent_events
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Definitive merger agreement signed Feb 8, 1998 to acquire Arbor Drugs in stock-for-stock merger valued ~$1.48B. Expected completion by March 31, 1998. No employee headcount disclosed.
1997-12-31restructuringin_progress1,0001997-04-011998-12-31United StatesAdministrative functionsUSD 90 (millions)MD&A
f5-10k / Qwen3.6-27B-Q8_0		Approximately 1,000 employees reduced, primarily in Revco's Twinsburg, Ohio headquarters. Severance charge of $89.8 million. Remaining balance expected to be incurred in 1998 and beyond.
1997-12-31restructuringcompleted1995-10-011997-12-31United StatesDiscontinued operationsUSD 35 (millions)MD&A
f5-10k / Qwen3.6-27B-Q8_0		Pre-tax charge of approximately $35 million recorded in Q2 1997 to finalize liabilities accrued in 1996. Program completed without significant changes to Board approved plan.
1997-09-27acquisition_additioncompleted1997-05-29United StatesRetail pharmacybusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Merger with Revco D.S., Inc. completed May 29, 1997; approximately 60.3 million CVS shares issued. Revco headcount added not disclosed; prior-period statements restated as pooling of interests.
1997-09-27divestiture_reductioncompleted1997-05-29United States (primarily Richmond, Virginia area)Retail storesrestructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Pursuant to FTC consent decree, 120 Revco stores divested in connection with the merger; associated headcount not disclosed.
1997-09-27restructuringin_progress1,0001997-05-29United States (primarily Twinsburg, Ohio headquarters)Corporate administration (consolidation of CVS and Revco administrative functions)USD 90 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Approximately 1,000 employees to be reduced via consolidation and facility closures. Total EITF 94-3 charge was $411.7M (severance $89.8M, exit costs $286.9M, transaction costs $35.0M); $91.7M utilized and $320.0M reserve balance at 9/27/97. Cash outlays primarily through 1998; $266.3M unpaid at quarter end.
1997-09-27restructuringin_progressUnited StatesStores, distribution and corporate administration (Big B, Inc. integration)USD 31 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Charge recorded in Q1 1997 for non-capitalizable Big B restructuring costs: $5.3M store/distribution/MIS conversion, $18.7M store closing, $7.0M duplicate headquarters. $12.1M of reserve utilized as of 9/27/97; affected-employee count not disclosed.
1997-09-27restructuringin_progress1,0001997-05-29Twinsburg, OhioAdministrative functionsUSD 90 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Reduction of approximately 1,000 employees primarily in Revco's headquarters through consolidation and closure of certain facilities. Part of $411.7M total merger-related charge.
1997-09-27restructuringin_progress1997-03-31Big B, Inc.USD 31 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Charge for non-capitalizable costs associated with restructuring of Big B, Inc., including store closing and duplicate headquarters costs. Employee count not specified.
1997-06-28restructuringin_progress1,000United StatesCorporate administration (primarily Revco Twinsburg, Ohio headquarters)USD 412 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Approximately 1,000 positions to be eliminated via consolidation and closure of facilities. Charge comprises $35.0M merger transaction costs, $89.8M employee severance, $286.9M exit costs; $53.7M non-cash asset write-offs, with $358.0M requiring cash outlays primarily in 1997 and 1998.
1997-06-28restructuringin_progressUnited StatesBig B, Inc. stores, distribution and headquartersUSD 31 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Recorded in first quarter 1997 for non-capitalizable costs of restructuring Big B, Inc. (acquired 1996): $5.3M store/distribution/MIS conversion, $18.7M store closing costs, $7.0M duplicate headquarters and administration. No employee count disclosed.
1997-06-28acquisition_additioncompleted1997-05-29United StatesRetail pharmacybusiness_combinations_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Merger completed May 29, 1997; approximately 60.3 million CVS shares exchanged for all Revco common stock (0.8842 exchange ratio), plus conversion of Revco options into options for ~3.3 million CVS shares. Accounted for as pooling of interests; no headcount added disclosed.
1997-06-28divestiture_reductionin_progressRichmond, Virginia area and other marketsRevco storesMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		FTC agreement requires divestiture of 120 Revco stores; 114 had been divested as of June 30, 1997. Store counts only — no associated employee count disclosed.
1997-06-28divestiture_reductioncompletedUnited StatesLinens 'n Thingsother
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Remaining investment in Linens 'n Things, Inc. sold in June 1997 for approximately $147.4M proceeds, pre-tax gain ~$65M; a pre-tax charge of ~$35M was recorded in discontinued operations to finalize previously accrued liabilities. No employee count disclosed.
1997-06-28restructuringin_progress1,0001997-05-29Twinsburg, OhioAdministrative functionsUSD 90 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Reduction of approximately 1,000 employees primarily in Revco's Twinsburg, Ohio Headquarters through consolidation and closure of certain facilities. Total merger-related charge was $411.7 million, including $35.0 million transaction costs and $286.9 million exit costs.
1997-06-28restructuringin_progress1997-01-01Big B, Inc.USD 31 (millions)restructuring_footnote
f5-10q / Qwen3.6-27B-Q8_0		Charge for non-capitalizable costs associated with restructuring of Big B, Inc., including store closing costs and duplicate headquarters and administration costs.
1996-12-31restructuringcompleted1,2001995-10-241996-12-31United StatesStore operationsrestructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Cumulative through fiscal year-end 1996 as part of the 1995 Plan. Approximately 1,200 store positions eliminated. Plan completed by Dec 31, 1996. Charge not separately allocated to this sub-component.
1996-12-31restructuringcompleted4001995-10-241996-12-31United StatesAdministrative / Corporaterestructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Cumulative through fiscal year-end 1996 as part of the 1995 Plan. Approximately 400 administrative positions eliminated. Plan completed by Dec 31, 1996. Charge not separately allocated to this sub-component.
1996-12-31divestiture_reductioncompleted1996-03-251996-05-04United StatesKay-Bee Toys divisionrestructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Sale of Kay-Bee Toys division to Consolidated Stores Corporation for approximately $285.7 million. Employee headcount not disclosed.
1996-12-31divestiture_reductioncompleted1996-03-251996-05-25United StatesWilsons divisionrestructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Sale of Wilsons division to investor group for approximately $69.7 million. Employee headcount not disclosed.
1996-12-31divestiture_reductioncompleted1996-03-251996-05-31United StatesThis End Up divisionrestructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Sale of This End Up division to investor group for approximately $18.2 million. Employee headcount not disclosed.
1996-12-31divestiture_reductioncompleted1996-09-241996-10-12United StatesFootstar, Inc. (Meldisco, Footaction, Thom McAn)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Spin-off of 100% of Footstar common stock to CVS shareholders. Employee headcount not disclosed.
1996-12-31divestiture_reductioncompleted1996-05-291996-12-02United StatesLinens 'n Things, Inc.restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		IPO of 67.5% of Linens 'n Things common stock for net proceeds of approximately $189.4 million. CVS retained 32.5% ownership. Employee headcount not disclosed.
1996-12-31restructuringcompleted1,2001995-10-231996-12-31United StatesStore employeesItem_1_Business
f5-10k / Qwen3.6-27B-Q8_0		Part of the 1995 Plan approved in Oct 1995. Positions eliminated for approximately 1,200 store employees. Plan completed by Dec 31, 1996.
1996-12-31restructuringcompleted4001995-10-231996-12-31United StatesAdministrative employeesItem_1_Business
f5-10k / Qwen3.6-27B-Q8_0		Part of the 1995 Plan approved in Oct 1995. Positions eliminated for approximately 400 administrative employees. Plan completed by Dec 31, 1996.
1996-09-28restructuringin_progress1995-10-01United StatesConsolidated (all segments)MD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Strategic restructuring initiated October 1995; includes cost reductions and closing of approximately 330 underperforming stores. No employee count disclosed.
1996-09-28divestiture_reductioncompleted1996-09-28United StatesApparel, toys and home furnishings segmentsother
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Dispositions of Marshalls, Kay-Bee Toys, Wilsons and This End Up divisions completed through September 28, 1996; associated headcount not disclosed.
1996-09-28restructuringin_progress1996-06-031997-06-30United StatesToys and home furnishings segment (Linens 'n Things, Bob's divisions)USD 148 (millions)MD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Formal plan announced June 3, 1996 to separate Linens 'n Things and Bob's divisions from CVS; one-time after-tax restructuring charge of approximately $148 million recorded in discontinued operations in Q2 1996. Charge covers both Separation Plans components.
1996-09-28plant_closureannounced1996-06-031997-06-30United StatesFootwear segment (Thom McAn)MD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Plan to convert 80 to 100 Thom McAn stores to the Footaction format and exit the Thom McAn business by mid-1997; store and employee counts not disclosed.
1996-09-28divestiture_reductionannounced1996-09-181997-12-31United StatesToys and home furnishings segment (Linens 'n Things)MD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Registration statement filed September 18, 1996 for public offering of Linens 'n Things shares; intention to dispose of entire ownership by end of 1997, subject to market conditions.
1996-09-28divestiture_reductioncompleted1996-09-241996-10-12United StatesFootwear segment (Footstar, Inc.)subsequent_events
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Spin-off of Footstar completed October 12, 1996 via distribution to shareholders of record October 2, 1996; announced after quarter end.
1996-09-28plant_closurecompleted1995-10-011996-09-28United StatesVarious (CVS, Footstar, Apparel, Toys/Home Furnishings)MD&A
f5-10q / Qwen3.6-27B-Q8_0		Closing of approximately 330 underperforming stores completed through September 28, 1996.
1996-09-28restructuringin_progress1996-06-03United StatesDiscontinued Operations (Linens 'n Things, Bob's, Thom McAn)USD 148 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0		One-time, after-tax restructuring charge of approximately $148 million recorded in Q2 1996 related to separation plans and store conversions.
1996-09-28divestiture_reductioncompleted1996-09-28United StatesApparel, Toys, Home FurnishingsMD&A
f5-10q / Qwen3.6-27B-Q8_0		Disposition of Marshalls, Kay-Bee Toys, Wilsons, and This End Up divisions completed through September 28, 1996.
1996-09-28divestiture_reductionannounced1996-10-121996-10-12United StatesFootwear (Footstar)subsequent_events
f5-10q / Qwen3.6-27B-Q8_0		Spin-off of Footstar completed on October 12, 1996, distributing 100% of shares to Melville shareholders.
1996-06-29restructuringin_progress1995-10-01United StatesMultiple divisionsUSD 148 (millions)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		One-time after-tax charge of ~$148M recorded in discontinued operations, primarily for separating Linens n Things and Bob's from CVS and exiting Thom McAn. Program includes closing ~330 underperforming stores. No employee count disclosed.
1996-06-29divestiture_reductioncompleted1995-11-17United StatesMarshalls (apparel)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Sold to The TJX Companies for ~$600M including $175M TJX preferred stock. No employee count disclosed.
1996-06-29divestiture_reductioncompleted1996-05-04United StatesKay-Bee Toys (toys)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Sold to Consolidated Stores Corporation for ~$315M including cash and a note receivable. No employee count disclosed.
1996-06-29divestiture_reductioncompleted1996-05-25United StatesWilsons (apparel)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Sold to investor group led by Wilsons management. Combined with This End Up sale for ~$87M total. No employee count disclosed.
1996-06-29divestiture_reductioncompleted1996-05-31United StatesThis End Up (home furnishings)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Sold to an investor group. Combined with Wilsons sale for ~$87M total. No employee count disclosed.
1996-06-29restructuringannounced1996-06-291997-06-30United StatesThom McAn (footwear)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Formal plan to convert 80 to 100 Thom McAn stores to Footaction format and exit Thom McAn business by mid-1997. No employee count disclosed.
1996-06-29restructuringannounced1996-06-29United StatesLinens 'n Things and Bob's (separation from CVS)restructuring_footnote
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Formal plan to separate Linens n Things and Bob's divisions from CVS as part of accelerating CVS emergence as stand-alone chain drug company. No employee count disclosed.
1996-06-29plant_closurein_progress1995-10-01United StatesMultiple divisionsMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Closing of approximately 330 underperforming stores as part of the strategic restructuring program. No employee count disclosed for closures.
1996-06-29restructuringin_progress1996-06-291997-06-30Footwear (Thom McAn)USD 148 (millions)MD&A
f5-10q / Qwen3.6-27B-Q8_0		Plan to convert 80-100 Thom McAn stores to Footaction format and exit Thom McAn business by mid-1997. Charge includes separation of Linens 'n Things and Bob's from CVS.
1996-06-29plant_closurecompleted1995-10-011996-06-29MD&A
f5-10q / Qwen3.6-27B-Q8_0		Closing of approximately 330 underperforming stores as part of strategic restructuring program initiated in 1994.
1996-03-30restructuringin_progress1995-10-24United StatesConsolidatedMD&A
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Comprehensive restructuring program referenced throughout the filing; no employee counts or severance amounts disclosed. Program includes fixed asset and goodwill write-offs.
1996-03-30divestiture_reductioncompleted1996-05-05United StatesToys and home furnishings (Kay-Bee division)subsequent_events
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Sale of Kay-Bee division to Consolidated Stores Corp. completed May 5, 1996 for approximately $315 million, including a $100 million four-year note. No headcount disclosed.
1996-03-30divestiture_reductionannounced1996-04-24United StatesToys and home furnishings (This End Up division)subsequent_events
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Definitive agreement signed April 24, 1996 to sell This End Up for approximately $19 million; expected to close in Q2 1996. No headcount disclosed.
1996-03-30divestiture_reductionannounced1995-10-241996-12-31United StatesFootwear segmentother
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Footwear segment to be spun off to shareholders during 1996 as part of the restructuring program; results classified as discontinued operations. No headcount disclosed.
1995-12-31restructuringin_progress1,6001995-10-241996-06-30United StatesMultiple — store operations and corporate administrationUSD 872 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Approximately 1,200 store and 400 administrative positions eliminated or to be eliminated as part of comprehensive restructuring announced 1995-10-24; includes store closures, corporate HQ closure, outsourcing of data processing and telecommunications; pre-tax charge of $872.0M
1995-12-31plant_closurein_progress1995-10-241996-12-31United StatesMultiple retail divisionsUSD 61 (millions)MD&A
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Approximately 330 stores designated for closure; ~270 closed as of 1996-01-31; balance to close as leases expire through 1996; charge covers tenancy and severance costs
1995-12-31divestiture_reductioncompleted1995-11-171995-11-17United StatesApparel — Marshalls off-price retailingUSD 245 (millions)restructuring_footnote
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Sale of Marshalls to The TJX Companies for ~$600M; pre-tax loss of $245.0M included in restructuring charge; headcount not separately disclosed
1995-12-31divestiture_reductionannounced1996-03-251996-05-31United StatesToys — Kay-Bee Toys divisionsubsequent_events
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Definitive agreement to sell Kay-Bee Toys to Consolidated Stores Corporation for ~$315M; expected close May 1996; headcount not disclosed
1995-12-31divestiture_reductionannounced1995-10-241996-06-30United StatesFootwear — Meldisco, Footaction, Thom McAnItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Planned spin-off of footwear segment to shareholders during 1996; classified as discontinued operations; headcount not disclosed
1995-12-31divestiture_reductionannounced1995-10-241996-06-30United StatesApparel — Wilsons and This End UpItem_1_Business
f5-10k / MiMo-V2.6-Flash-fp8-HTML		Company announced intention to sell Wilsons and This End Up businesses; negotiations in progress; expected completion by summer 1996; headcount not disclosed
1995-12-31restructuringin_progress1,6001995-10-241996-06-30United StatesCorporate and Various DivisionsUSD 48 (millions)restructuring_footnote
f5-10k / Qwen3.6-27B-Q8_0		Positions for approximately 1,200 store employees and 400 administrative employees eliminated or to be eliminated. Severance charge of $48.0 million recorded. Program expected to be completed by summer 1996.
1995-12-31plant_closurein_progress1995-10-241996-12-31United StatesVarious Retail DivisionsUSD 61 (millions)MD&A
f5-10k / Qwen3.6-27B-Q8_0		Closure of 330 stores and several warehouses. Charge of $61.4 million for estimated tenancy and severance costs. As of Jan 31, 1996, approx 270 stores closed; balance expected to close as leases expire throughout 1996.
1995-09-30divestiture_reductionannounced1995-10-141995-12-31United StatesApparel (Marshalls division)USD 195 (millions)subsequent_events
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Agreement to sell Marshalls to The TJX Companies for $550 million ($375M cash, $175M TJX convertible preferred); after-tax charge of approximately $195 million expected upon closing in Q4 1995. No employee count disclosed.
1995-09-30restructuringannounced1995-10-241996-12-31United StatesCorporate-wide; creation of three independent public retailing companies (chain drug, footwear, toy)USD 585 (millions)subsequent_events
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Program includes spin-offs of footwear businesses and Kay-Bee, retention of CVS with Linens 'n Things and Bob's in the chain drug holding company, consolidation of Meldisco/Footaction/Thom McAn functions, and corporate overhead reduction; also includes early adoption of SFAS 121 and a change in software cost accounting. After-tax charge of approximately $585 million (in addition to the $195 million Marshalls charge). No employee count disclosed.
1995-09-30plant_closureannounced1995-10-241996-12-31United StatesRetail stores and warehouses (multiple divisions)subsequent_events
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Approximately 330 stores and several warehouses to be closed as part of the restructuring; charge for this sub-component not separately disclosed (included in the overall approximately $585 million after-tax program charge). No employee count disclosed.
1995-09-30divestiture_reductionannounced1995-10-241996-12-31United StatesApparel (Wilsons and This End Up divisions)subsequent_events
f5-10q / MiMo-V2.6-Flash-fp8-HTML		Company plans to pursue sales of the Wilsons and This End Up chains during 1996 as part of the restructuring announced 1995-10-24. No employee count or separate charge disclosed.
1995-09-30restructuringannounced1995-10-24Corporate overhead, Meldisco, Footaction, Thom McAnUSD 585 (millions)subsequent_events
f5-10q / Qwen3.6-27B-Q8_0		Comprehensive strategic restructuring including creation of three independent companies, sale of Wilsons and This End Up, closure of approx 330 stores and several warehouses, consolidation of functions, and reduction of corporate overhead. Charge is after-tax.
1995-09-30plant_closureannounced1995-10-24Retail Storessubsequent_events
f5-10q / Qwen3.6-27B-Q8_0		Closure of approximately 330 stores as part of the comprehensive strategic restructuring program.
1995-09-30divestiture_reductionannounced1995-10-141995-12-31Marshalls divisionUSD 195 (millions)subsequent_events
f5-10q / Qwen3.6-27B-Q8_0		Agreement to sell Marshalls division to The TJX Companies, Inc. Transaction expected to close in Q4 1995. After-tax charge of approx $195 million to be recorded.